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CHAPTER I 
INTRODUCTION AND REVIEW OF THE RELATED LITERATURE 
CHAPTER I 
INTRODUCTION AND REVIEW OF THE RELATED LITERATURE 
A. THE BIOSYNTHESIS OF HEME 
All aerobic cells except the normal, mature, non-
nucleated erythrocyte synthesize heme, a quadridentate che-
1 1 f h 1 h . . h F +2 ate comp ex o t e tetrapyrro e protoporp yr1n w1t e 
Numerous hemoproteins including hemoglobin, myoglobin, cata-
lase, peroxidases, and cytochromes owe their activity, at 
least in part, to heme. Heme therefore functions as a pros-
thetic group for oxygen transport, plays an important role 
in electron transport, and is involved in the detoxification 
of a variety of xenobiotics. The biosynthetic pathway lead-
ing to the formation of heme is the same regardless of its 
site of synthesis or its ultimate function (FIGURE 1) 
(Harris and Kellermeyer, 1970). 
The synthesis of heme begins with the condensation of 
the ubiquitous and readily available amino acid glycine and 
the citric acid cycle intermediate succinyl CoA, with the 
elimination of carbon dioxide, to form delta-aminolevulinic 
acid (ALA). This reaction is catalyzed by the mito-
chondrial enzyme delta-aminolevulinic acid synthetase 
(ALAS), the only enzyme of heme synthesis requiring a co-
factor (pyridoxal phosphate) and to which energy must be 
2 
p 
3 
supplied (in the form of activated succinate) (Granick, 
1958; Kikuchi et al., 1958). The level of ALAS is the most 
important rate limiting factor in the heme biosynthetic 
pathway, being induced by certain sex hormones and drugs 
(such as barbiturates) and being repressed by heme (Granick, 
1966; Granick and Kappas, 1967; Kappas and Granick, 1968). 
Heme also inhibits the activity of ALAS in a negative feed-
back fashion (Burnham and Lascelles, 1963; Karibian and 
London, 1965). Finally, the synthesis of ALAS can be in-
duced by erythropoietin with the subsequent appearance of 
the other enzymes of heme synthesis (Nakao et al., 1968a). 
The substituted monopyrrole precursor of all tetra-
pyrroles, porphobilinogen (PBG), was first isolated by 
Westal (1952) from the urine of a porphyric human and char-
acterized by Cookson and Rimington (1953). Dresel and Falk 
(1953) recognized the possibility that the aromatic com-
pound PBG might be formed by the condensation of two mole-
cules of the aliphatic compound ALA and postulated the ex-
istence of an enzyme catalyzing this reaction. This soluble 
cytoplasmic enzyme delta-aminolevulinic acid dehydratase 
(ALAD; EC 4.2.1.24), which is present in all aerobic cells 
including the normal, mature, non-nucleated erythrocyte, was 
first isolated from ox liver by Gibson and co-workers (1955). 
These investigators demonstrated that ALAD requires thiol 
groups for activity and is inhibited in vitro by millimolar 
+2 + +2 +2 concentrations of Pb , Ag , Cu , and Hg , heavy metals 
with a high affinity for sulfhydryl groups (Oehme, 1972). 
They further demonstrated that ALAD is inhibited in vitro 
4 
by ethylenediaminetetraacetate (EDTA), a chelator of cer-
tain divalent metal ions (Martel and Calvin, 1952), strongly 
suggesting involvement of metal ions in the enzymatic mech-
anism (Parisi and Vallee, 1969). Heme has been reported to 
inhibit ALAD in a negative feedback fashion (Calissano et 
al., 1966). 
In the succeeding step of heme synthesis four mole-
cules of PBG condense, under the control of two cytoplasmic 
enzymes, to form the tetrapyrrole ring compound uroporphy-
rinogen III. These two enzymes are readily distinguished 
on the basis of their susceptibility to heat inactivation. 
PBG deaminase (PD), which is also called uroporphyrinogen 
I synthetase, is quite heat stable (Bogorad and Granick, 
1953) and catalyzes the removal of the amino group from PBG. 
PD also catalyzes the head-to-tail condensation of four in-
dividual pyrroles into the symmetrical uroporphyrinogen I. 
The second enzyme is uroporphyrinogen isomerase (UI) or uro-
porphyrinogen III cosynthetase and is quite unstable to 
heat, being rapidly inactivated at 60°C (Bogorad and Granick, 
1953). UI will not, when free of PD, react with PBG or uro-
porphyrinogen I (Bogorad, 1958). The exact mechanism of the 
conversion of four molecules of PBG to uroporphyrinogen III 
by the combined action of PD and UI remains unclear (Gidari 
and Levere, 1977). 
p 
5 
The four acetic acid side chains of uroporphyrinogen 
III are enzymatically decarboxylated by the action of the 
soluble cytoplasmic enzyme uroporphyrinogen decarboxylase 
(UD) to produce coproporphyrinogen III (Mauzerall and 
Granick, 1958). This enzyme is active only on the fully 
reduced porphyrinogen (Batlle and Grinstein, 1962). UD de-
carboxylates the type III isomer at 7.5 times the rate of 
the type I isomer when present in equal concentrations and 
requires no cofactor (Cornford, 1964). 
The conversion of coproporphyrinogen III to protopor-
phyrin IX is complex. The propionate groups at positions 
2 and 4 of coproporphyrinogen III are decarboxylated and 
oxidized by the mitochondrial enzyme coproporphyrinogen 
decarboxylase (CD) resulting in the formation of protopor-
phyrinogen IX (Granick and Mauzerall, 1958a). This enzyme 
has no activity toward the coproporphyrinogen I isomer and 
requires no cofactor (Batlle et al., 1965). Six hydrogens 
are then enzymatically removed from protoporphyrinogen IX 
to yield protoporphyrin IX but until recently it was uncer-
tain whether the enzyme catalyzing this reaction is CD or 
another enzyme (Sano and Granick, 1961). In 1976 Poulson 
demonstrated that there is indeed a second enzyme specific 
for protoporphyrinogen IX, protoporphyrinogen IX oxidase 
(POx) . 
Heme is formed by the insertion of ferrous, but not 
ferric, iron into the protoporphyrin IX ring in a reaction 
p 
catalyzed by the enzyme heme synthetase (HS) or ferrochela-
tase (Hasegawa et al., 1970). HS is a mitochondrial enzyme 
(Jones and Jones, 1969) stimulated by reduced glutathione 
and inhibited by lead (Goldberg et al., 1956). In addition 
HS is inducible and subject to end-product inhibition by 
heme (Hasegawa et al., 1970). 
6 
There is a normal physiologic coordination between the 
synthesis of heme and the synthesis of globin (Morell et al., 
1958). It has been demonstrated that, in addition to in-
hibiting its own formation, heme enhances globin synthesis 
(Bruns and London, 1965). Furthermore, depletion of avail-
able heme results in a suppression of the biosynthesis of 
globin (Heywood et al., 1972). Thus the self-regulated 
availability of heme provides the coordination between the 
synthesis of heme and the synthesis of globin. 
•• 
B. THE MOLECULAR PROPERTIES OF ALAD 
1. THE BASIC PROPERTIES OF ALAD 
ALAD isolated from bacterial (Nandi et al., 1968; Van 
Heyningen and Shemin, 1971; Nandi and Shemin, 1973), plant 
(Tigier et al., 1970), and mammalian· (Doyle, 1971; Gurba et 
al., 1972; Wilson et al., 1972; Cheh and Neilands, 1973; Wu 
- --
et al., 1974) sources and purified to varying degrees has 
been described as having a molecular weight between 240,000 
and 290,000. The ALAD of Rhodopseudomonas spheroides (Van 
Heyningen and Shemin, 1971) and mouse liver (Doyle, 1971) 
is reported to be composed of six subunits and that from 
7 
bovine and rat liver of six or seven subunits (Gurba et·al., 
1972), each with a subunit molecular weight of 40,000. Beef 
liver ALAD was later reported to contain seven dimeric sub-
units with molecular weights of 35,500 (Wilson et al., 1972) 
and seven or eight subunits with molecular weights of 36,000 
(Cheh and Neilands, 1973). Wu and associates (1974) found 
bovine liver ALAD to be composed of eight similar subunits 
with subunit molecular masses of 35,000; this is consistent 
with its electron microscopic appearance as discrete lobes 
arranged at the corners of a cube. Shemin (1976) attributed 
the discrepancies in the number of reported subunits to the 
lack of sufficient material from the various sources rather 
than to actual differences in the enzyme from the various 
sources. 
p 
8 
It is well established that ALAD is inhibited in a 
negative feedback fashion by heme (Burnham and Lascelles, 
1963; Coleman, 1966; Calissano et al., 1966). In addition, 
the enzyme activity plotted as a function of substrate con-
centration and of cysteine concentration is sigmoidal (Nandi 
et al., 1968; Vergnano et al., 1968a). These facts, to-
-- -- --
gether with the fact that the enzyme is composed of sub-
units, suggests that ALAD is an allosteric enzyme (Gerhardt 
and Pardee, 1962; Martin, 1963; Monod et al., 1963). 
ALAD from every source studied has been found to be-
have like a typical sulfhydryl enzyme (Shemin, 1972). 
Wilson and fellow workers (1972) demonstrated the presence 
of 56 cysteine residues per molecule of beef liver ALAD, ap-
proximately half of which are involved in inter- or intra-
subunit disulfide linkages while the others, as determined 
by titration with p-chloromercuribenzoate (Erwin and Peder-
sen, 1968), are free. The report by Shemin (1976) of seven 
cysteine residues per subunit is in complete agreement with 
this while the report of Tsukamoto et al. (1975) of nine 
cysteine residues per subunit is slightly at odds. Both 
authors report that two or three sulfhydryl groups are read-
ily titrated with (5,5'-dithiobis(2-nitrobenzoic acid)) 
(Ellman, 1959) only after activation with exogenous thiols 
or after denaturation of the enzyme, implying involvement in 
disulfide linkage or existence in a buried position in the 
enzyme. In the presence of the competitive inhibitor 
• 
9 
levulinic acid only one sulfhydryl group can be titrated, 
implying its presence at the active site and, possibly, the 
formation of a thiohemiketal between it and the second, non-
Schiff base bound ALA molecule. One consequence of the 
sulfhydryl nature of ALAD is that on purification the sulf-
hydryl groups become oxidized and the enzyme inactive; the 
activity of the enzyme can be restored by the addition of 
thiol activating reagents such as reduced glutathione 
(GSH), dithiothreitol, and cysteine. In addition, being 
a sulfhydryl enzyme ALAD is susceptible to inhibition by 
heavy metal ions which have a high affinity for sulfhydryl 
groups (Oehme, 1972). 
Crude preparations of mouse liver ALAD have been re-
ported to be activated by the in vitro addition of EDTA 
while EDTA has no effect on the purified enzyme (Coleman, 
1966). ALAD from~- spheroides and~- capsulata is similar-
ly unaffected by EDTA (Nandi and Shemin, 1973). In vitro 
EDTA, however, does inhibit ALAD from all other reported 
bacterial (Yamasaki and Moriyama, 1971), fungal (Komai and 
Neilands, 1969), yeast (DeBarreiro, 1967), plant (Nandi and 
Waygood, 1967; Shetty and Miller, 1969; Tigier et al., 1970; 
Schneider, 1970), and animal (Gurba et al., 1972; Wilson et 
al., 1972; Yamada, 1972; Border et al., 1976a) sources, 
strongly suggesting the involvement of divalent metal ions 
in the mechanism of the ALAD from these sources (Parisi and 
Vallee, 1969). 
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2. THE EFFECT OF METAL IONS ON ALAD ACTIVITY 
It appears that ALAD, regardless of source, has the 
same molecular mass, number of subunits, sulfhydryl charac-
ter, metal ion requirement for maximal activity, and al-
losteric nature. The exact nature of the effect of metal 
ions, with the exception of lead (which will be discussed 
further in other sections), on ALAD activity in vitro and 
in vivo seems, however, to depend on the source of the en-
zyme and even then there is often disagreement. 
Komai and Neilands (1968) found that ALAD activity in 
crude extracts of the smut fungus Ustilago sphaerogena grown 
in its sporoidal stage depends on the concentration of zn+2 
in the culture media. Enzyme activity is not lost on dialy-
sis of the crude extracts and in vitro addition of zn+2 has 
no effect on the enzyme up to 10-4 M when it is inhibitory. 
They, therefore, concluded that Zn+2 is necessary for the 
synthesis of ALAD at the translation level but did not pre-
clude the possible presence of a firmly bound essential 
. +2 +2 +2 
metal ion s~nce Zn , Fe , and, to a lesser extent, Cd 
enhance the activity of the purified enzyme as well as that 
treated with chelating agents. In a subsequent paper (1969) 
+ they reported that Cu chelating agents are powerful inhib-
itors of the enzyme and there is a moderately good correla-
tion between the activity of ALAD from U. sphaerogena and 
its copper content after purification. The ligand-treated 
enzyme from U. sphaerogena cannot be reconstituted by Cu+2 
• 
because it is a potent inhibitor but it can be reactivated 
by zn+Z which is isoelectronic with Cu+. 
11 
ALAD from the yeast Saccharomyces cervisiae is also 
inhibited by millimolar concentrations of Cu+2 as well as by 
Hg+2 while Mg+2 is added to the enzyme preparation without 
effect (DeBarreiro, 1967). Divalent magnesium at a concen-
tration of 3.3 mM is, however, necessary for the maximum ac-
tivity of the ALAD from Mycobacterium phlei. At a concen-
+2 tration 0.33 mM, Mg can reverse the EDTA-induced inhibi-
tion of the enzyme from this source (Yamasaki and Moriyama, 
1971). 
ALAD from the photosynthetic bacteria R. spheroides 
and ~· capsulata is the only ALAD unaffected by EDTA. A 
purified and well-dialyzed preparation of ALAD from R. cap-
sulata is active without the addition of any cation but mil-
limolar concentrations of either Fe+2 or Fe+3 inhibit the 
enzyme (Nandi and Shemin, 1973). The enzyme from~· spher-
oides requires K+ or a related ion such as Li+, Rb+, NH4+, 
M +2 f . . 1 b . or g or act~vat~on at ow su strate concentrat~ons 
(Nandi et al., 1968). In the presence of these ions the en-
zyme associates into a mixture of monomer, dimer, and trimer 
(Nandi and Shemin, 1968a). 
Wheat leaf ALAD is completely inhibited by millimolar 
concentrations of Cu+2 and Hg+2 while the same concentration 
of Na+, K+, Fe+2 , Co+2 , Ni+2 , Zn+2 , and Pb+2 is without ef-
fect on the enzyme. A 10-4 M concentration of Mg+2 , Ca+2 , 
p 
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or Mn+2 can activate wheat leaf ALAD, the activation by 
Mn+2 being able to overcome inhibition by EDTA in a stoichio-
metric fashion (Nandi and Waygood, 1967). Tobacco leaf ALAD 
is inhibited by low concentrations of both Fe+2 and EDTA; low 
concentrations of both Mg+2 and Mn+2 partially reverse the 
inhibition of ALAD by EDTA but at higher concentrations only 
Mg+2 is an activator (Shetty and Miller, 1969). It has been 
reported by Schneider (1970) that ALAD from spinach leaves 
is inactive after dialysis and application of EDTA but is 
reactivated by +2 to a lesser degree, Mn+2 low Mg and, con-
centrations of c +2 a ' F +2 e , and Zn+
2 inhibit the enzyme from 
this source but Na+, K+, and NH4+ are without effect. In 
contrast to this, Tigier et al. (1970) reported the maximum 
activity of ALAD from the soybean callus is observed when it 
is grown is a culture medium containing 10-6 M Zn+2 and con-
cluded Zn+2 is essential for enzyme synthesis. 
The divalent cations Mg+2 , Ca+2 , Ba+2 , Mn+2 , Fe+2 , and 
Zn+2 have no effect on mouse liver ALAD while Cu+2 and Pb+2 
inhibit the enzyme at low concentrations. ALAD from this 
source is moderately activated by Fe+2 at 10-3 M and more 
markedly activated by Hg+2 at 10-4 to 10-3 M which can also 
prevent the inhibition of ALAD by 10-S M Cu+2 (Coleman, 
1966). 
Tomio and co-investigators (1968) found that neither 
purified ALAD nor the crude preparation from the rat Harder-
ian gland requires the addition of any metal ion for maximal 
p 
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activity. H C +2 Hg+2 owever, u , + +2 Ag , and Pb , each at a fi-
nal concentration of 0.1 to 1.0 mM, inhibit the enzyme. 
While millimolar concentrations of MgC1 2 have a moderate in-
hibitory effect on the enzyme, when Mg+2 is added as the 
sulfate it activates the enzyme as do the sulfate salts of 
NH + and K+. 4 
Rat erythrocyte ALAD has been reported to be activated 
to 250% of control activity by 2 mM Al+3 , to 240% of control 
activity by 0.18 mM Zn+2 , and to 360% of control activity by 
the combination of the two (Meredith et al., 1974). Mere-
dith and associates also report that aluminum sulfate acti-
vates rat liver ALAD in vivo. Zinc also affects erythro-
cytic ALAD in vivo for its activity is markedly decreased 
when the rats are fed a low zinc diet. The in vitro addi-
tion of Zn+2 to hemolysates of zn+2 deficient rats results 
in only a slight increase in ALAD activity, suggesting zn+2 
is required at the level of ALAD synthesis (Finelli et al., 
1974; Finelli et al., 1975). 
In an early report of the metal content of ALAD puri-
fied from beef liver, Iodice et al. (1958) found 0.1% copper 
in the enzyme with magnesium being the only other metal pre-
sent. Gurba and associates (1972), on the other hand, re-
ported the hepatic ALAD to contain approximately 1 g-atom 
of zinc per 270,000 g of protein as well as smaller, non-
stoichiometric amounts of iron and cobalt. 
According to Cheh and Neilands (1973) the ALAD from 
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bovine liver contains 1.2 g-atoms of zinc per mole of enzyme 
and possesses only 25% of the activity ultimately observed 
after titration with between 5 and 6 g-atoms of Zn+2 per 
mole. This represents the upper limit of the Zn+2 require-
ment because kinetic and competitive factors diminish the 
effectiveness of added metal hence only half of the 7 or 8 
subunits of the enzyme must be involved in Zn+2 binding. 
+2 These investigators also reported that Cd restores full 
activity to the purified enzyme but Mg+2 , Ca+2 , Cr+3 , Fe+2 , 
Fe+3 , Ni+2 , Cu+, and Cu+2 are inactive. Shemin (1976) sim-
ilarly found, by determining the number of atoms of Zn+2 
per mole of enzyme necessary to restore full activity to 
the bovine apo-enzyme, that the enzyme contains 4 to 6 atoms 
of zinc per molecule of enzyme. It was further discovered 
h h dd . . f z +2 . . ff . . . . t at t e a ~t~on o n ~s ~ne ect~ve ~n restor~ng act~v-
ity to the purified enzyme unless it is first reduced by a 
reduced thiol. 
The activity of beef liver ALAD inhibited by 10 ~M 
EDTA can be completely restored by 100 ~M Zn+2 which is 
considered by Wilson et al. (1972) to be an absolute re-
quirement for the enzyme. In addition, they reported that 
1 mM zn+2 is a competitive inhibitor of ALAD, 100 ~M Mg+2 , 
Ca+2 , Fe+2 , and Cu+2 have no effect on the enzyme, and 100 
M Cd+2 . . . th 1 b t t . ~ ~s un~que ~n at at ow su s ra e concentrat~ons 
it inhibits ALAD while at higher substrate concentrations 
it activates the enzyme. In a rather unusual study Ramp 
p 
and Kriebitzsch (1975) found that both +2 500 ~M Zn and 100 
~M Cd+2 enhance the activity of bovine erythrocytic ALAD 
when stored with the enzyme for two to six weeks at -30°C. 
The effect of various metal ions on purified human 
erythrocytic ALAD,was investigated by Ca1issano et al. 
(1965) who found K+, Mg+2 , Ca+2 , and Fe+3 to be without ef-
fect on the enzyme while Mn+2 and Co+2 are weak and Pb+2 , 
+ +2 +2 Ag , Cu , and Hg are powerful inhibitors of the enzyme. 
On the other hand, Fe+2 stimulates ALAD at all concentra-
tions from 5 x 10-6 M to 5 x 10-3 M and zn+2 stimulates 
ALAD at all concentrations between 5 x 10-5 M and 5 x 10-4 
M while inhibiting it at 5 x 10-3 M. According to Collier 
(1971) a fresh hemolysate dialyzed against a solution of 
EDTA has only 10% of the activity of an undialyzed prepara-
tion and its activity can only be restored by Mn+2 Milli-
1 . f F +2 d C +2 . h"b"t h d" 1 mo ar concentrat~ons o e an o ~n ~ ~ t e un ~a yz-
d C +2 h ff . d Mn+2 . . e enzyme, a as no e ect on ~t, an act~vates ~t. 
Abdulla and Haeger-Aronsen (1971) incubated various 
concentrations of Zn+2 with a human whole blood hemolysate 
for four hours and found that 4.6 X 10-5 M zn+2 inhibits 
-
4 d 1.5 x lo- 3 M zn+2 ALAD slightly while 7.6 x 10 Man 
stimulate the enzyme to 172 and 201% of the control acti-
vity, respectively. These investigators also reported the 
oral administration of 30 to 40 mg of zn+2 (as the sulfate) 
per day for four weeks in one volunteer resulted in a sue-
cessive increase in erythrocytic ALAD activity but they 
15 
jP 
16 
presented no actual data for this. 
The effects of Mg+2 , Ca+2 , Mn+2 , Co+2 , Ni+2 , Zn+2 , 
Cd+2 , and Hg+2 at concentrations ranging from 10-7 M to 
10- 2 M on the ALAD activity of human whole blood hemoly-
sates was investigated by Mitchell and associates (1977). 
They discovered that both Cd+2 and Hg+2 stimulate ALAD at 
10- 5 M before inhibiting it at higher concentrations, zn+2 
stimulates the enzyme maximally at 10- 4 M but at no concen-
tration is it inhibitory, and the other ions are without 
effect. They also found that +2 Zn can protect ALAD against 
inhibition by EDTA down to 10-l M EDTA and that the stimu-
lation of the enzyme by Zn+2 is additive with that by sulf-
hydryl reagents, implying different mechanisms of stimula-
tion. 
The inhibition or ALAD by the in vitro addition of 
EDTA is well established but its in vivo effect has only 
recently been studied. At a plasma EDTA concentration of 
0.2 to 0.4 mM a 5% decrease in the erythrocytic ALAD acti-
vity and a 14% decrease in the hepatic ALAD activity of the 
normal rat is observed while at the same plasma concentra-
tions in vivo lead-induced inhibition of hepatic ALAD is 
almost completely reversed (Hammond, 1973). These effects 
of EDTA on ALAD in vivo apparently also occur in man. In 
lead-intoxicated children treated with Na2 (Ca-EDTA) there is 
a transient increase in serum and urinary ALA concentrations 
(possibly reflecting a further inhibition of the enzyme by 
p 
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EDTA) followed by a rapid and pronounced fall in both serum 
and urinary ALA concentrations (reflecting removal of the 
lead from, hence reactivation of, ALAD) (Chisolm, 1968a). 
Trisodium calcium diethylenetriaminepentaacetate, 
Na3 (ca-DTPA), the most effective and widely used chelation 
agent for reducing actinide contamination in man, has an 
ability to remove zinc that is approximately 100 times more 
than that of Na2 (ca-EDTA) (Catsch et al., 1968). In ba-
boons treated with Na3 (Ca-DTPA), whenever the concentration 
of Zn+Z in the catheterized urine was greater than approxi-
mately four times the normal value erythrocytic ALAD acti-
vity was decreased to less than one-half of the normal va-
lue (Cohen and Guilmette, 1976). In patients with cirrho-
sis a similar effect is observed for in these patients a 
40% decrease in plasma zinc concentrations and a 48% de-
crease in erythrocytic ALAD activity has been observed. 
The fact that the activity of ALAD in patients with cirrho-
sis is less enhanced by the in vitro addition of Zn+Z than 
it is in lead intoxicated patients led these investigators 
to conclude there is a decreased synthesis of ALAD as a re-
sult of the decrease in zn+Z (Allain et al., 1977). 
Copper deficiency may not have the same effect on 
erythrocytic ALAD activity zinc deficiency has. In a single 
patient receiving intravenous feedings containing insuffi-
cient copper, a copper deficiency anemia resulted but the 
erythrocytic ALAD activity was normal. This is consistent 
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with the observation of the same researchers that the eryth-
rocytic ALAD activity in rats fed a copper deficient diet 
containing adequate levels of zinc is normal (Finelli et 
al., 1974). This, however, is in marked contrast to the 
observation that hepatic ALAD activity in rats and erythro-
cytic ALAD activity in ducklings is decreased 30 to 50% if 
dietary copper is missing (Iodice et al., 1958). 
There are three heavy metals that are generally re-
cognized as being ubiquitous environmental contaminants: 
lead, mercury, and cadmium (Vallee and Ulmer, 1972). The 
in vivo effect of each of these on human erythrocytic ALAD 
activity has been investigated. Wada et al. (1969) found 
a moderate decrease in the ALAD activity of workers occu-
pationally exposed to mercury below the old threshold limit 
value (TLV) of 0.1 mg/m3 whose urinary mercury exceeded 
200 ~g/gm creatinine; neither ALAD activity nor urinary 
mercury levels, however, correlated with the erythrocyte 
glutathione levels or the urinary ALA excretion, which were 
normal in all cases. Among workers exposed to mercury 
3 vapor below the new TLV of 0.05 mg/m and at the exposure 
level of the general population there is no decrease in 
erythrocytic AL~D activity or increase in urinary ALA 
(Lauwerys and Buchet, 1973). This same group of i~vesti-
gators also found that occupational exposure to cadmium has 
no effect on ALAD activity, urinary ALA excretion, or red 
cell glutathione levels (Lauwerys et al., 1973; Reels et 
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al., 1975). Thus of the three metals generally recognized 
-
as environmental contaminants only lead causes a significant 
in ~ inhibition of erythrocytic ALAD. 
I . . . h s +2 t ~s ~nterest~ng to note t at n which has the 
same electronic configuration as Pb+2 , inhibits erythro-
cytic ALAD activity when administered intraveneously to rab-
bits but Sn+4 does not (Chiba and Kikuchi, 1978). 
Thus, while there is no universal agreement with re-
spect to the metal ion requirement of ALAD, there does ap-
pear to be nearly unanimous agreement that the enzyme loses 
activity on purification. This appears to be due to the 
tendency of ALAD to lose its metal ion on purification or 
to the oxidation of its many sulfhydryl groups on purifi-
cation or to both. 
While there is no agreement about the metal ion re-
quirement of ALAD it is, nonetheless, tempting to speculate 
that: the enzyme from anaerobic microbial sources which 
synthesize the cobalt-containing porphyrin vitamin B12 
. C + Z +2 M +2 h f h h . . requ~res u , n , or g ; t at rom p otosynt et~c m~cro-
organisms which synthesize the manganese-containing porphy-
+2 +2 +2 
rin chlorophyll requires Ca Mg , or Mn ; ALAD from 
eukaryotic microorganisms and mammalian sources which syn-
+ thesize the iron-containing porphyrin heme require Cu , 
zn+2 , or Fe+2 . However, while on the basis of the current 
evidence there is considerable overlap of metal ion require-
ments for ALAD but no consensus, the generalizations with 
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respect to the metal ion requirement of ALAD based on the 
ultimate destination of the porphyrin moiety appears unjust-
ified. Clearly, further work is necessary to clarify the 
exact nature of the metal ion requirement of ALAD from the 
various sources. 
3. THE MECHANISM OF PORPHOBILINOGEN SYNTHESIS 
A Schiff base is an imine resulting from the conden-
sation of an amine and a carbonyl-containing compound such 
as an aldehyde or a ketone (Snell and DiMari, 1970): 
+ ) 
amine aldehyde or ketone imine 
Incubation of an enzyme with the substrate in the presence 
of sodium borohydride (NaBH4) with the consequent loss of 
enzymatic activity confirms the formation of a Schiff base 
between the carbonyl group of the substrate and the epsilon-
amino group of a lysyl residue of the enzyme. Concomitant 
with the loss of enzymatic activity is a stoichiometric 
binding of radioactive substrate to the enzyme (Horecker 
et al., 1963; Grazi et al., 1963). 
ALAD from g. spheroides (Nandi and Shemin, 1968b; Van 
Heyningen and Shemin, 1971), R. capsulata (Nandi and Shemin, 
1973), mouse liver (Doyle, 1971) and bovine and rat liver 
(Gurba et al., 1972) is almost completely inactivated by 
NaBH4 in the presence of 
14c ALA with radioactivity bound 
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to the enzyme in a stoichiometric ratio. The formation of 
a Schiff base by one molecule of ALA with ALAD precludes 
the initial formation of a Schiff base between the two sub-
strate molecules. Furthermore, the formation of a Schiff 
base between ALA and ALAD results in a stabilized carbanion 
which can make a nucleophilic attack onto the carbonyl car-
bon of a second molecule of ALA resulting in an aldol con-
densation. There is then an enzyme catalyzed elimination of 
water between the carbon atom bearing the newly formed hy-
droxyl group and the adjacent carbon atom. In the final 
step the amino group of the ALA molecule not in Schiff base 
linkage with the enzyme makes a nucleophilic attack on the 
highly reactive carbon atom in Schiff base linkage with the 
enzyme resulting in the formation of a gem diamine. The 
amino group of the enzyme then leaves the gem diamine and 
the conjugated pyrrole PBG, which is no longer able to re-
act with the enzyme, is formed. The formation of PBG in 
this manner (i.e. transamination) serves two purposes; it 
is a trap driving the reaction to completion and it pro-
vides a mechanism for freeing the product from the active 
site of the enzyme (Nandi and Shemin, 1968b). 
In an extension of this mechanism Cheh and Neilands 
(1974) proposed the participation of divalent zinc in a 
Lewis acid polarization of the carbonyl group of the second 
molecule of ALA, facilitating the nucleophilic attack of 
the first, Schiff base-bound, substrate molecule. 
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The observation that only four of the eight subunits 
of ALAD form a Schiff base with ALA indicates the enzyme 
exhibits the phenomenon of negative cooperativity and half-
site reactivity (Shemin, 1976). That is, the maximal stoi-
chiometric yield of an enzyme-'-substrate covalent inter-
mediate or product in a single turnover is equal to half 
the number of apparently equivalent active sites. This is 
a consequence of the peculiar quaternary structure of the 
native enzyme or the native enzyme-substrate intermediate 
resulting in the absence of a twofold axis of symmetry in 
the oligomeric state (Seydoux et al., 1974). 
Batlle and co-workers (1978) investigated the disso-
ciation, reassociation, and rehybridization of bovine liver 
ALAD attached to Sepharose. They found that each catalytic 
site of the enzyme could function independently of the 
other within-a dimeric formation. They, therefore, postu-
lated (Batlle and Stella, 1978) that the minimum structure 
necessary for enzymatic activity is a dimer having one sub-
unit involved in the formation of a Schiff base with one 
molecule of ALA while the second subunit binds noncovalently 
with the second molecule of ALA, holding it in place. The 
histidine residue present in each of the active sites 
(Tsukamoto et al., 1975) are, in this model, assigned the 
role of transferring protons to and from the active center 
of the basic mechanism described above. The two subunits 
are held together, according to this model, at intersubunit 
p 
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contact sites by ionic, covalent, coordinate covalent, 
or hydrogen bonds in which the sulfhydryl groups of the en-
zyme as well as the metal activator (e.g. divalent zinc) 
participate. 
The half site reactivity of a functional dimer cata-
lyzing this rather rare reaction in which two identical sub-
strate molecules participate would help explain the early 
observation of Granick and Mauzerall (1958b) that the affin-
ity of ALAD for the first molecule of ALA is at least ten 
times greater than its affinity for the second. The first 
molecule binds covalently to one subunit while the second 
molecule binds noncovalently to the second subunit. 
4. THE ACTIVATION OF LEAD-INHIBITED ALAD BY THIOLS, METAL 
IONS, pH CHANGE, AND HEATING 
Lead inhibits ALAD from all mammalian sources in 
vivo and in vitro in a noncompetitive fashion (Wilson et 
al., 1972; Sassa et al., 1975). The inhibition of ALAD 
can, nonetheless, be reversed both in vitro and in vivo. 
The in vivo and in vitro inhibition of erythrocytic 
ALAD caused by lead can be reversed by the in vitro addition 
of thiol compounds including reduced glutathione (Lichtman 
and Feldman, 1963), cysteine (Bonsignore et al., 1965), and 
dithiothreitol (Granick et al., 1973). The reactivation of 
the lead inhibited ALAD by thiols is considered to be the 
result of a thiol-mercaptide exchange between the added 
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thiol and the lead-sulfhydryl complex of the lead inhibited 
enzyme. Hapke and Prigge (1973) attributed the difference 
in thiol activated ALAD between a lead contaminated group 
and a control group to a normalization of the free part of 
the enzyme by a resynthesis of the enzyme. 
Granick and fellow investigators (1973) found an ex-
cellent correlation between blood lead levels and the ratio 
of thiol activated ALAD activity to nonactivated ALAD activ-
ity. The linearity of this ratio, which eliminates the 
broad distribution of ALAD activities due to genetic varia-
tion (Sassa et al., 1975), down to unity at a blood lead 
level of 15 ~g per 100 ml of whole blood led these workers 
to conclude that this is the threshold for the effect of 
lead on ALAD. Below this concentration they assume lead 
binds to some group (perhaps on the erythrocyte membrane) 
with a higher affinity for lead than ALAD. 
These results have led some to hypothesize that the 
endogenous concentration of GSH in erythrocytes plays a 
regulatory role in the activity of ALAD (Moore et al., 1971) 
and that this control mechanism might be affected by lead 
(DeBarreiro, 1969). Indeed, there is a well established 
moderate but significant decrease in the endogenous erythro-
cyte GSH concentration in lead intoxicated workers (Shi-
raishi, 1952; Rubino et al., 1963; Batolska and Marinova, 
1970). Furthermore, one group reports that the in vivo ad-
ministration of GSH to lead intoxicated workers improved 
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the decreased ALAD to some extent (Nakao et .al., 1968b). 
Abdulla and Haeger-Aronsen (1973) observed that rela-
tively high concentrations of zinc could antagonize the 
heavy metal-induced inhibition of erythrocytic ALAD in 
vitro. Finelli and fellow workers (1975) have reported the 
reversal of the in vivo and in vitro lead-induced inhibi-
tion of erythrocytic ALAD by the in vitro addition of diva-
lent zinc. These authors also noted a protective effect of 
zinc on the inhibitory effect of lead during in vivo studies 
on rats. They suggested the in vivo stimulation of lead 
inhibited ALAD by zinc can be a useful tool for the diagno-
sis of lead intoxication. Their conclusion, on the basis 
of these results, was that zinc is functioning at the active 
site of ALAD, possibly at sulfhydryl groups, to displace 
lead and thereby reactivate the enzyme. 
In 1976 Haust and associates reported the case of a 7 
year old lead poisoned girl with pica who had inadvertently 
ingested approximately 5 g of zinc oxide. These workers 
noted a tenfold increase in erythrocytic ALAD activity on 
day 5 after the ingestion and another, less dramatic, rise 
on day 13 after the ingestion of zinc and another on day 17. 
These increases in erythrocytic ALAD activity were related 
to increases in red cell zinc provided there was no con-
comitant increase in red cell lead or copper. 
Aluminum has been reported to activate in vitro lead 
inhibited erythrocytic ALAD in vitro and hepatic ALAD 
p 
activity in vivo (Meredith et al., 1974). These observa-
tions, however, should be viewed with caution since these 
authors used a 0.5 M potassium phosphate buffer which 
might interfere with the results (Finelli et al., 1974). 
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Mitchell et al. (1977) used an assay incorporating 
both divalent zinc and a thiol compound, GSH, with incuba-
tion with the substrate at 50°C for 10 to 20 minutes. The 
extent of activation of normal erythrocytic ALAD by zinc 
and by GSH was found to be similar but the combined effects 
were additive, suggesting these two agents activate ALAD by 
different mechanisms. The natural logarithm of the ratio 
of activated e.rythrocytic ALAD activity to nonactivated 
erythrocytic ALAD activity was found to be directly pro-
portional to the blood lead concentration with the correla-
tion between these two values being higher than that report-
ed by Granick and co-workers (1973) for their GSH activated 
system as reported above. 
Nikkanen and associates (1972) have demonstrated that 
the optimum pH for erythrocytic ALAD determination is lower 
in persons occupationally exposed to lead than in normal 
individuals. Using this observation, Tomokuni (1974) found 
the rate of decrease of the ratio of erythrocytic ALAD ac-
tivity determined at pH 6.8 to that determined at pH 6.0 to 
be proportional to the increase of the blood lead level. 
From these results Tomokuni concluded that lead regulates 
ALAD activity from an allosteric site on the molecule which 
p 
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changes in conformation as the pH is lowered, thereby pre-
venting lead from interfering with the active site of the 
enzyme. 
ALAD is remarkably heat stable, being capable of 
withstanding temperatures as high as 60°C for at least 20 
minutes without significant loss of activity (Coleman, 1966; 
Nandi et al., 1968; Wilson et al., 1972). The reaction 
rate increases nearly linearly with increasing temperature 
up to 60°C with the reaction rate at 50°C being nearly 
three times that at 37°C (Mitchell et al., 1977). The 
thermal stability of ALAD can be exploited to determine 
whether or not ALAD is a regulatory enzyme because mild 
heating is classically employed to make such enzymes insen-
sitive to metabolite inhibition at allosteric sites (Ger-
hardt and Pardee, 1962; Martin, 1963; Monod et al., 1963). 
Several groups of investigators have used the tech-
nique of heating the whole blood hemolysate at 60°C for 
5 minutes prior to incubation with substrate in order to 
determine the mechanism by which lead inhibits ALAD with 
mixed success and contradictory conclusions (Bonsignore et 
al., 1968; Vergnano et al., 1968b; Tomokuni and Kawanishi, 
1975; Chiba, 1976). There was complete agreement that the 
heat treatment reversed the inhibitory effect of lead on 
erythrocytic ALAD if the inhibition was due to chronic in 
vivo exposure to lead. There was similar agreement that 
the heat treatment potentiated lead-induced inhibition if 
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lead was added to a hemolysate of normal blood prior to pre-
incubation and weakened the inhibitory action of lead if it 
was added to a normal blood hemolysate after preincubation. 
On the other hand, the ALAD activity of a liver homogenate 
was actually decreased by the heat treatment (Coleman, 1966; 
Vergnano et al., 1968b). These results led Vergnano et al. 
(1968b) and Tomokuni and Kawanishi (1975) to conclude that 
lead causes an allosteric modification of the active site 
resulting in enzymatic inhibition. Bonsignore et al., 
(1968) concluded, on the basis of the same results, that 
the lead-induced inhibition of ALAD is due to the action of 
a thermolabile allosteric effector or to a structural modi-
fication at the level of synthesis of the enzyme or to the 
variation in the level of a phantom normal isoenzyme. 
Chiba (1976) hypothesizes the existence of two components 
of erythrocytic ALAD: type 1, inherently active without 
heat treatment, is inhibited by lead in a mannner that can-
not be restored by heat treatment; type 2, inherently in-
active without heat treatment and relatively insensitive to 
lead, may be inactivated by higher concentrations of lead. 
The explanation offered by Chiba appears to be the most 
reasonable especially if one imagines the type 2 ALAD to be 
that fraction of all ALAD inhibited in a negative feedback 
fashion by heme (Calissano et al., 1966), the level of 
which could be increased in chronic lead intoxication as a 
result of hemolysis (Hernberg et al., 1967; Berk et al., 
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1970). Indeed both the degree of hemolysis (Hernberg et 
al., 1967) and the ratio of heat treated erythrocytic ALAD 
activity to unheated erythrocytic ALAD activity (Tomokuni 
and Kawanishi, 1975; Chiba, 1976) are directly proportional 
to the blood lead level. 
The basic conclusion derived from the reactivation of 
lead-inhibited erythrocytic ALAD by thiols, metal ions, pH 
change, and heating is that lead inhibits the enzymatic 
activity directly and does not inhibit the synthesis of the 
enzyme. What is still open to question is whether this in-
hibition is at the active site or at an allosteric site. 
In addition, the assessment of erythrocytic ALAD 
activity with and without activation of the enzyme by 
thiols, metal ions, pH change, or heating and the calcula-
tion of the simple ratio of activated to nonactivated ALAD 
activity has several advantages over the use of the non-
activated ALAD assay in the assessment of lead intoxication. 
These advantages have been summarized by Mitchell and asso-
.ciates (1977) and include: 
a. the ratio increases with an increase in the blood 
lead level and is more closely correlated with it 
than is the erythrocytic ALAD activity alone 
b. the units of enzyme activity need not be computed 
thus avoiding the confusion of the many different 
methods of expressing the erythrocytic ALAD activity 
c. the results do not need to be normalized by use of 
p 
the hemoglobin concentration or the hematocrit 
d. the broad range of enzymatic activity resulting 
from genetic differences in erythrocytic ALAD 
activity is eliminated as a source of error 
e. activation of the enzyme provides a positive 
internal control of the test. 
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c. THE ACTIVITY OF ALAD IN DISEASE STATES 
1. THE ACTIVITY OF ALAD IN CERTAIN M~EMIAS 
The components of the heme biosynthetic pathway in the 
erythrocyte are sensitive to changes in red cell turnover 
and red cell age in both health and disease as well as to a 
variety of genetic, developmental, and environmental factors 
(Harris and Kellermeyer, 1970) and ALAD is no exception. 
For example, human erythrocytic ALAD is inherited in a co-
dominant fashion resulting in a broad range of enzymatic 
activity (Sassa et al., 1973a). As additional examples, 
repeated phlebotomy (Abdulla et al., 1975), phenylhydrazine-
induced (i.e. hemolytic) anemia (Abdulla and Svensson, 1978), 
and iron deficiency anemia (Sharma, 1973) in rats stimulate 
erythropoiesis and a subsequent increase in ALAD activity 
which can be correlated with a greater number of circulating 
reticulocytes. It is, therefore, not surprising that 
changes in erythrocytic ALAD activity in a variety of human 
anemias, both before and after the initiation of therapy, 
have been reported. These reports, however, have not always 
been in agreement. 
A hemolytic disease exists in any situation in which 
the in vivo life span of the erythrocyte is shorter than 
normal. The hemolytic process is considered to be compen-
sated if the rate of red cell destruction is such that an 
increase in erythrocyte production can compensate for the 
, 
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excessive destruction. A compensated hemolytic process is 
generally reflected by a partial shift of reticulocytes from 
the bone marrow to the peripheral blood. In severe, albeit 
at least partially compensated, hemolytic anemias due to 
hemoglobinopathies (including SS, SC, and S-S-thalassemia) 
and other, miscellaneous, causes (e.g. autoimmune hemolytic 
anemia) as well as in compensated mild hemolysis (e.g. B-
thalassemia trait) ALAD activity is significantly increased. 
In addition, the increase in erythrocytic ALAD activity in 
these hemolytic diseases is clearly associated with an in-
crease in the number of reticulocytes (Rubino et al., 1960; 
Feldman and Lichtman, 1964; Anderson et al., 1977). 
The megaloblastic anemias are due to varying degrees 
of abnormality in the metabolism of vitamin B12 or folic 
acid or both together. The result of this abnormal metabo-
lism is ineffective erythropoiesis producing, if untreated, 
an uncompensated macrocytic, hypochromic anemia. In the 
megaloblastic anemias due to vitamin B12 or folic acid 
deficiencies erythrocytic ALAD activity is reported to be 
both decreased (Rubino et al., 1960) and increased with no 
substantial difference in technique hence no ready explana-
tion for the discrepency in the results (Battistini et al., 
1971). Both authors, however, agree that the activity of 
erythrocytic ALAD increases with the reticulocyte response 
during the response to the appropriate therapy. 
Iron lack or deficiency anemia is an uncompensated 
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hypochromic microcytic anemia due to depletion of the iron 
normally available to meet metabolic requirements. In iron 
deficiency anemia erythrocytic ALAD activity has been re-
ported to be unchanged (Rubino et al., 1960; Lichtman and 
Feldman, 1963; Prato et al., 1968; Gutniak et al., 1971; 
Battistini et al., 1971) and increased (Heilmeyer, 1964; 
Kaneko, 1970; Mazza et al., 1971; Chalevelakis et al., 1977). 
The explanation of this difference is suggested by the obser-
vation of Sharma (1973) that the enzyme activity in iron 
deficient rats was unchanged when expressed as units/ml of 
blood but was increased when more properly expressed as 
units/ml of packed red cells. There is, nonetheless, agree-
ment that the activity of erythrocytic ALAD increases with 
the reticulocyte response during therapy (Rubino et al., 
1960; Mazza et al., 1971). 
The association of an increase in erythrocytic ALAD 
activity with the reticulocytosis of hemolytic anemia as 
well as with that associated with the response of vitamin 
B12 , folic acid, and iron deficiency anemias to appropriate 
therapy has an important implication. A decrease in the 
components of the heme biosynthetic pathway with red cell 
ageing is anticipated because hemoglobin synthesis is active 
in bone marrow erythroid cells and reticulocytes but not in 
circulating mature erythrocytes that have lost their cellu-
lar organelles. These observations suggest that with the 
maturation of the erythrocyte, in addition to the loss of 
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mitochondrial heme biosynthetic enzymes, there is a more 
gradual decline in the activity of the soluble cytoplasmic 
enzyme ALAD. The decline in enzymatic activity could re-
flect a degradation of enzyme protein or another mechanism 
such as the loss of a cofactor or the progressive increase 
in the concentration of an inhibitor. To evaluate the mech-
anism of the decline in ALAD activity with an increase in 
the age of the erythrocyte population it might be important 
to have an experimental model in which there is little 
genetic variation in enzymatic activity but varying degrees 
of a naturally occurring reticulocytosis. 
2. AN ANIMAL MODEL FOR STUDYING THE ASSOCIATION OF ERYTHRO-
CYTIC ALAD ACTIVITY viTTH RETICULOCYTOSIS 
The neonatal and developing rat is a potentially use-
ful model for studying the relationship between erythrocytic 
ALAD activity and the degree of reticulocytosis. A macro-
cytic hypochromic anemia is characteristic of the early 
neonatal peri~d of the rat. This anemia appears to be a 
partially compensated hemolytic anemia in light of the 
erythroid hyperplasia, the increased rate of macrocyte 
disappearance, and the increased degree of reticulocytosis 
(ranging from 89% at day 1 to 29% at day 10 and 3.7% at day 
40) that has been observed (Lucarelli et al., 1964). These 
unique features had initially suggested that erythropoietic 
activity in the neonatal rat is governed by a mechanism 
p 
35 
different than that of the adult (Lucarelli et al., 1968). 
It has, however, subsequently been demonstrated that 
erythropoiesis in the neonatal rat is indeed regulated by 
the same hypoxia-erythropoietin mechanism present in the 
adult (Matoth and Zaizov, 1970; Zaizov and Matoth, 1970). 
The unique hematologic picture presented by the newborn and 
developing rat is a reflection of the transition from 
hepatic to bone marrow erythropoiesis, a transition similar 
in many ways to that observed during the last trimester of 
normal human gestation (Michels, 1931). 
A preliminary observation that adult rats weighing 
200 g or more had approximately one-half of the erythrocytic 
ALAD activity of younger animals weighing 100 g or less 
(Finelli et al., 1974) suggests that there may indeed be a 
correlation between erythrocytic ALAD activity and reticulo-
cyte percent in the developing rat. If that were indeed the 
case, the developing rat could provide a useful model for 
investigating the mechanism of the decline of erythrocytic 
ALAD activity with an increase in the age of the cell. In 
addition, it could serve to demonstrate an important source 
of variability in lead poisoning analysis in newborn and 
developing rats. 
3. THE ACTIVITY OF ALAD IN LEAD POISONING ANEMIA 
The important hematologic finding in lead poisoning is 
anemia which is perhaps the best understood effect of lead 
, 
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in man. A decrease in the blood hemoglobin concentration 
begins to appear at relatively low levels of lead exposure; 
the ultimate anemia can be constant and severe in children 
(Watson et al., 1958) but is generally mild in the adult 
(Rubino et al., 1959; Griggs, 1964; Waldron, 1966) except 
at very high levels of exposure when a frank anemia is 
observed (Williams, 1966). The threshold of blood lead 
exposure for the appearance of anemia appears to be a blood 
lead level of 40 ~g/100 ml in children (Pueschel et al., 
1972; Betts et al., 1973) and 50 ~g/100 ml in adults (Tola 
et al., 1973). The anemia is typically normocytic and 
slightly hypochromic (Fullerton, 1952) and the reticulocyte 
percent is usually elevated to the 2 to 7% range. The mild 
anemia found in most patients with lead poisoning appears 
to be the result of several different effects of lead. 
Lead has a direct, hemolytic action on the erythrocyte 
resulting in a moderate shortening of the erythrocyte survi-
val time that can be correlated with anemia, reticulocytosis, 
and blood lead levels (Hernberg et al., 1967). These 
authors found the erythrocyte destruction to be nonrandom, 
indicating lead shortens the true life span of the erythro-
cyte, but others found a random shortening of the red cell 
life span (Berk et al., 1970). The shortening of the red 
cell life span is of such a degree that the bone marrow 
should be able to adequately compensate and hemoglobin 
depression should not be observed. That hemoglobin 
, 
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depression is observed suggests that lead also inhibits the 
production of erythrocytes by the bone marrow. 
There is indeed direct evidence for lead inhibition of 
both heme and globin biosynthesis. In acute lead poisoning 
the synthesis of globin has been demonstrated to be markedly 
disturbed although the investigators were unable to deter-
mine whether or not this was primarily due to lead acting at 
some level in globin synthesis (White and Harvey, 1972). It 
was subsequently demonstrated that the abnormality in the 
synthesis of globin seen in lead poisoning occurs only 
secondarily to a deficit in the production of heme (Pidding-
ton and White, 1974). The deficit in heme production is the 
consequence of the inhibition of the two heme biosynthetic 
enzymes that are sensitive to lead. 
Gibson and Goldberg (1970) measured heme synthetase . 
activity of brain, liver, kidney, and bone marrow in rats 
exposed subacutely to parenteral lead and found no inhibi-
tion by lead. They did, however, find that the addition of 
lead acetate in concentrations similar to those present in 
the original unhomogenized tissues, 10-4 H, produced marked 
inhibition of HS. A direct consequence of HS inhibition in 
vivo is an increase in the concentration of protoporphyrin 
IX in the blood (generally referred to as free erthrocytic 
protoporphyrin-FEP-or zinc protoporphyrin-ZnP) which is 
directly proportional to the blood lead levels in patients 
without iron deficiency (Granick et al., 1972; Chisolm et 
al., 1974; Piomelli, 1977). Since the erythrocyte has no 
-
mitochondria, an increase in FEP reflects bone marrow lead 
effects and chronic lead poisoning (Sassa et al., 1973b). 
ALAD is the other heme biosynthetic enzyme for which 
there is substantial evidence of lead-induced inhibition. 
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Ever since Bonsignore et al. (1965) unequivocally estab-
lished that erythrocytic ALAD is markedly inhibited in both 
acute and chronic lead poisoning, it has repeatedly been 
demonstrated that the activity of erythrocytic ALAD is in-
versely proportional to the blood lead level. This in vivo 
dose-response relationship has been demonstrated in frank 
as well as in sub-clinical lead poisoning (DeBruin, 1968; 
Nakao et al. , 1968b; Hernberg et al. , 1970; Haeger-Aronsen 
et al., 1971; Weissberg et al., 1971; Hcintire et al., 
1973) and in the normal urban population as a result of 
environmental lead pollution (Hernberg and Nikkanen, 1970; 
Secchi et al., 1971). 
The threshold level for the inhibition of ALAD by lead 
is 15 ~g of lead per 100 ml of whole blood (Granick et al., 
1973) and this effect is linear to a level of 120 ~g of lead 
per 100 ml of whole blood (Roels et al., 1974). The obser-
vation of most investigators that ALAD that is 90% inhibited 
in vivo or in vitro by relatively high concentrations of 
lead cannot be further inhibited by lead was confirmed by 
Goldstein and associates (1975) in baboons administered lead 
intravenously or orally for nearly six months. The failure 
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to demonstrate a continued decrease in ALAD activity after 
90% inhibition by lead led Weissberg and fellmv workers 
(1971) to conclude that this is the limit of the sensitivity 
of the assay. However, this may actually represent a 
natural biochemical process since the -SH groups of ALAD are 
protected from oxidation in the presence of the substrate 
ALA (Granick et al., 1973) which may increase in lead 
poisoning to such a level that it protects that enzyme not 
yet inhibited by lead. Alternatively, the normal endogenous 
levels of GSH or some metal activator of ALAD may be high 
enough to prevent or reverse the lead-induced inhibition of 
10% of erythrocytic ALAD. 
Aside from providing an extremely sensitive measure of 
the degree of lead exposure, the inhibition of erythrocytic 
ALAD is of questionable significance since the erythrocyte 
lacks the mitochondrial enzymes participating in heme syn-
thesis. However, inhibition of erythrocytic ALAD is prob-
ably a reflection of the inhibition of the enzyme in the 
erythroid precursors of the bone marrow. In addition, a 
correlation between erythrocytic ALAD activity and the 
activity of liver ALAD in man (Secchi et al., 1974) and 
between erythrocytic ALAD activity and the activity of liver 
and brain ALAD in lead poisoned suckling rats (Millar et al., 
1970) has been demonstrated. The consequences of this are 
as yet undetermined but potentially highly significant. 
One known and well established consequence of the 
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inhibition of ALAD by lead is the marked increase in the 
urinary excretion of ALA. Urinary ALA excretion rises above 
normal limits in an exponential fashion in both adults 
(Haeger-Aronsen, 1960; Selander and Cramer, 1970) and chil-
dren (Davis et al., 1968). Raised urinary ALA concentra-
tions are closely correlated with plasma levels that are 
elevated prior to the urinary increase (Haeger-Aronsen, 1960; 
Chisolm, 1968b). The source of this increased urinary and 
plasma ALA was suggested by Gibson and Goldberg (1970) who 
showed that, in rabbits treated with chronic parenteral lead 
acetate, liver, kidney, and bone marrow ALA increases to 
levels 2, 12, and 100 times the control levels, respectively 
The blood lead threshold for the elevation of plasma and 
urinary ALA is approximately 45 ~g of lead per 100 ml of 
whole blood, which is appreciably higher than that for ALAD 
inhibition, suggesting the body has a considerable function-
al ALAD reserve (Lauwerys et al., 1974). 
4. THE POSSIBLE CONSEQUENCES OF ALA ACCUMULATION 
Acute intermittent porphyria (AIP) is a genetically 
controlled disease of a chronic nature; the genetic defect 
involves the overproduction of ALA in the liver as a result 
of the induction of ALAS (Marver and Schmid, 1972) and a 
decreased metabolism of ALA to heme due to a partial lack of 
PD activity (Meyer et al., 1972) resulting in an increased 
excretion of ALA and PBG. One consequence of the elevated 
p 
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hepatic ALA biosynthesis and decreased ALA metabolism is an 
increase in the plasma and cerebrospinal fluid concentra-
tions of ALA (Sweeney et al., 1970). ~fuen ALA reaches the 
serum equilibrium levels seen in AIP it has been demonstrat-
ed to pass into various organs of the body including the 
heart and gut (McGillion et al., 1975). In addition, as 
suggested by the increase in the cerebrospinal fluid concen-
tration of ALA, the elevated plasma concentration can pass 
the blood-brain barrier and enter the brain tissue (Kramer 
et al., 1971; McGillion et al., 1974); Becker et al. (1974), 
using rabbit brain cortical slices, actually demonstrated 
brain uptake of ALA via an active transport-like system. 
Thus in both AIP and lead poisoning there is an increase in 
tissue and plasma ALA concentrations as well as an increased 
urinary excretion of ALA. 
The signs and symptoms of 50 cases of lead poisoning 
have been compared with those of 50 cases of patients suf-
fering from AIP and striking similarities have been observ-
ed (Dagg et al., 1965). The porphyria triad of abdominal 
pain, constipation, and vomiting was found to be the most 
common symptom complex of lead poisoning. The incidence 
and distribution of non-abdominal pain were nearly identical. 
In addition, neuropsychiatric manifestations, paresis or 
paralysis, paresthesias, and cardiovascular abnormalities 
(including tachycardia and hypertension) were observed in 
both diseases but the incidence and severity were generally 
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greater in AIP. Finally, there is a notable similarity of 
the pathologic changes affecting the nervous system in both 
diseases which includes a segmental demyelination of the 
peripheral nerves. 
Purified porphyrins and PBG have been demonstrated to 
be pharmacologically inactive (Goldberg et al., 1954) as has 
ALA (Jarrett et al., 1956). Nonetheless, the clinical and 
pathologic similarities between AIP and lead poisoning sug-
gest, despite different etiologies of the diseases, are-
lated pathogenesis. The possibility that the common feature 
of these diseases, the increased levels of ALA, may be the 
underlying cause of the clinical and pathologic similarities 
is, therefore, being reinvestigated. The possible direct 
toxic effect of ALA in the pathogenesis of an acute attack 
of AIP (hence, possibly, in lead poisoning) is further 
implied by the recent observation (Dhar et al., 1975) of a 
clinical remission and the return to normal of elevated 
plasma ALA levels after infusion of hematin which, it will 
be recalled, inhibits ALAS. 
In studying the pathogenesis of the hypertension and 
tachycardia seen in AIP several investigators have found a 
significant correlation between both blood pressure and 
pulse rate and the amount of urinary catecholamines excret-
ed (Schley et al., 1970; Atuk et al., 1975). The etiology 
of the increased excretion of catecholamines was, until 
recently, unclear. In 1977 Beal and associates demonstrated 
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a significantly reduced platelet uptake and accumulation of 
norepinephrine (NE) in the presence of both 1 and 10 ~M 
ALA in patients with AIP but no similar reduction in the 
platelets of normal patients. The AIP patients' platelets 
were by no means deficient in uptake capacity since their 
control uptake of NE was actually greater than that of 
platelets from normal controls and NE uptake could be sig-
nificantly decreased in both patients with AIP and normal 
patients by desmethylimipramine. Both the significantly 
greater control platelet uptake of NE and the significantly 
decreased platelet uptake of NE in the presence of ALA led 
these investigators to conclude that there is a latent 
defect in catecholamine uptake or accumulation in the plate-
lets of patients with AIP which becomes apparent only in the 
presence of ALA. Since platelet uptake serves as a model of 
adrenergic neuronal uptake (Abrams and Solomon, 1969; Born 
and Smith, 1970) and reuptake is the principle means of 
terminating the physiologic action of NE in vivo (Molino££ 
and Axelrod, 1971), the elevated circulating catecholamines 
observed during acute attacks of AIP could be caused, at 
least in part, by blocked reuptake of catecholamines into 
adrenergic neurons (Beal et al., 1977). It would be inter-
esting to look for a similar latent defect in those lead 
intoxicated individuals with hypertension and tachycardia. 
Isoniazid produces a pattern of denervation in rats 
that is similar to that observed in AIP (Cavanagh, 1967) . 
44 
The principle toxic action of isoniazid is the depletion of 
pyridoxal phosphate by increasing the excretion of pyridoxal 
(Holtz and Palm, 1964). It is likely that the neurologic 
lesion is a result of tissue deprivation of this cofactor 
since it can be reversed or prevented by pyridoxal phosphate 
(Zbinden and Studer, 1955). The similar patterns of denerva-
tion led Cavanagh and Ridley (1967) to postulate a similar 
etiology in AIP. That is, the excessive activity of the 
pyridoxal phosphate-requiring enzyme ALAS leads to a rela-
tive tissue depletion of pyridoxal phosphate and the 
observed neurologic lesion. However, no correlation between 
plasma pyridoxal phosphate levels and neuropathy was 
observed in patients with AIP and those with low pyridoxal 
phosphate levels did not improve after the administration 
of the vitamin (Hamfelt and Wetterberg, 1968). Thus, while 
a relative pyridoxal phosphate deficiency might have explain-
ed the denervation and, because of decreased levels of gamma-
amino-butyric acid (GABA) (due to the inhibition of the 
pyridoxal phosphate-dependent enzyme of GABA synthesis, 
glutamic acid decarboxylase) (Roberts, 1963), the other 
neurologic features of AIP, factors other than this must be 
responsible. 
The structural similarity of ALA and GABA, a ubiqui-
tous inhibitory transmitter in the central nervous system 
(Johnston, 1978), suggests that ALA might interact with GABA 
receptors. Nicoll (1976) studied the perfused frog spinal 
F 
cord using the sucrose gap technique and found that ALA, 
added to the preparation in a Ringer solution at pH 7.3, 
activates GABA receptors on motoneurons, hyperpolarizing 
them, and on primary afferent fibers, reducing transmitter 
release from them in response to incoming volleys. The 
threshold concentration for the effect of ALA reported by 
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Nicoll is 2 to 5 x 10-5 H while that for the effect of GABA 
-5 II is 10 M. Muller and Snyder (1977) found that concentra-
tions of ALA causing postsynaptic and presynaptic inhibition 
in the frog spinal cord preparation compete with GABA for 
crude synaptic membrane Na+-independent GABA receptor bind-
ing on frog and rat spinal cords as well as on rat brain 
synaptosomes. Both studies demonstrated the relative 
potencies of GABA and ALA are more alike in their effect on 
postsynaptic than on presynaptic inhibition. In addition, 
Becker et al. (1976) showed that ALA causes an increased 
release of GABA from both stimulated (at 0.5 11H) and non-
stimulated (at 100 11H) rabbit cerebral cortex synaptosomes. 
Muscimol, a potent GABA-mimicking drug, causes ataxia, 
muscle weakness, slowing of thought processes, dysphoria, 
and occasional psychotomimetic effects with hallucinations 
(Theobald et al., 1968), symptoms reminiscent of the muscle 
weakness and psychiatric symptoms observed in AIP and lead 
poisoning (Goldberg, 1959; Roth, 1968). It is therefore 
possible that some of the symptoms of AIP and lead poisoning 
may be the result of the effect of ALA on GABA receptors as 
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well as on GABA release. 
A direct presynaptic inhibitory effect of 0.6 to 18 mM 
ALA at the cholinergic synapse of the rat neuromyal junc-
tion was demonstrated in 1979 by Bornstein and fellow work-
ers. Thus, ALA causes a decrease in the number of quanta of 
acetylcholine (ACh) released by a nerve impulse but has no 
effect on the depolarization produced by a single quantum of 
ACh or on the postsynaptic resting membrane potential. 
Becker and co-workers (1971) showed that 10-4 to 2 x 
10 - 3 ~"" ALA .;nh.;b.;ts a N + K+ · d d· · · h ~l ~ ~ ~ a , -act~vate a enos~ne tr~p os-
phatase (Na,K-ATPase) in rabbit erythrocyte and brain mem-
branes. This enzyme helps to maintain the Na+ and K+ 
gradient across the cell membrane and inhibition by ALA 
would cause the membrane to become leaky with a resulting 
decrease in resting membrane potential and a possible block 
of nerve conduction. More recently Becker and associates 
(1975), using electrophysiologic techniques, demonstrated 
that ALA can produce a relatively rapid and large decrease 
in the resting membrane potential of a single fiper from 
the sartorius muscle of the frog in a reversible and dose 
-4 dependent manner over a concentration range of 10 to 
10- 3 M. 1 This decrease is not likely to be mediated sole y 
by an inhibition of the Na,K-ATPase· but probably also 
involves an alteration in membrane permeability to Na+ and 
K+ by unknown mechanisms possibly involving the release of a 
depolarizing substance. 
The in vitro effects described above occur, for the 
most part, at a concentration (10-4 M) at least ten times 
higher than that typically found in the plasma of patients 
with lead poisoning and acute attacks of AIP (10- 6 to 10-5 
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M) . This has caused some to question whether circulating 
ALA is toxic and led to the speculation of another endoge-
nous or induced defect of heme synthesis within the nervous 
system that is responsible for the symptoms of AIP and lead 
poisoning (Shanley et al., 1976; Shanley et al., 1977). 
D. THE PHYSICAL AND CHEMICAL PROPERTIES OF METAL IONS 
1. THE ELECTRON CONFIGURATION (Weidner and Sells, 1968; 
Cotton and Wilkinson, 1972) 
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An atom of an element of atomic number Z consists of a 
small, dense nucleus composed of neutral particles, neutrons, 
and Z positively charged particles, protons, embedded in a 
cloud of Z considerably smaller and less massive negatively 
charged particles, electrons. While the electron cloud is 
highly dynamic, the arrangement of electrons around the nu-
cleus of an element can be described in terms of occupation 
of orbitals within successive energy levels. This is re-
ferred to as the electron configuration of an element. The 
physical and chemical properties of an element are largely 
dependent on its electron configuration and elements with 
similar electron configurations have similar properties. 
Electrons of an atom occupy successive principal energy 
levels designated by ~ and of positive integral values with 
the values of n equal to 1, 2, 3, 4, 5, and 6 corresponding 
to the K, L, M, N, 0, and P shells, respectively. Principal 
energy levels are divided into sublevels designated by l 
which has integral values from 0 to (~-1) with the values 
of 1 equal to 0, 1, 2, and 3 corresponding to the ~· £• d, 
and f sublevels, respectively. The ~. £, ~. and f sub-
levels have (21 + 1) orbitals, each of equal energy but 
each with a different spatial orientation in the presence 
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of an external magnetic field. These spatial orientations 
are designated by the orbital magnetic, ~l' which has the 
intergral values~. 1-1, ... , 0, ... , 1-l, -1. Each orbital 
can have a maximum of two electrons with parallel and op-
posite' spin magnetics, designated m, with a value of 
-s 
either +% or -%. 
Although the principal energy levels represent the 
general order of magnitude of the energy of an electron, the 
least stable sublevels of one principal energy level may be 
of higher energy than the most stable sublevels of the next 
higher level hence will fill after them. Furthermore, ac-
cording to Hund's Rule orbitals of one sublevel accommodate 
single electrons of parallel spins in each before the 
pairing of electrons in the orbitals in that sublevel be-
gins. 
The numbers £, ~. ~1 , and ~s are known as quantum num-
bers. According to the Pauli Exclusion Principle no two 
electrons of an atom have the same set of quantum numbers; 
this is the basis of the structure of the Periodic Table. 
When the unique set of quantum numbers for each and every 
electron in an atom is known, the electron configuration of 
the atom is established. According to the famous Pauli 
Aufbauprinzip, the different orbitals, each with its unique 
set of quantum numbers, are arranged in order of increasing 
energy (1~, 2~, 2£, 3~, 3£, 4~, 3~, 4~, 5~, 4~, 5£, 6~, 4f, 
5~. 6£) and the electrons placed into the orbital of lowest 
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energy until all Z electrons have been accommodated. The 
periodicity of electron configurations is a result of the 
recurrent filling of successive principal energy levels; the 
periodicity of chemical properties reflects the periodicity 
of the electronic configurations. Each column of the Perio-
dic Table contains elements with similar electron configura-
tions hence similar chemical properties. 
Certain electron configurations are more stable than 
others. The electron configurations of the noble gases, 
which have two s electrons and six £ electrons in their out-
er shells, are especially stable. Configurations in which 
subshells are either filled or half filled are also quite 
stable. It is the tendency of atoms to acquire either 
closed shell electron configurations of noble gases or 
filled or half filled subshells through the sharing of 
electrons with other atoms (covalent bond formation) or 
through electron transfer (the formation of ionic bonds) 
that accounts for their oxidation states. 
Each electron orbital is a well defined region in 
space in which the electrons of that orbital are most 
likely to be found. As mentioned above, each orbital has a 
different spatial orientation. If one imagines the atomic 
nucleus to be situated at the origin of three mutually per-
pendicular Cartesian axes (x, y, and z) it is possible to 
describe the spatial orientation of the orbitals of the 
three subshells usually involved in the formation of 
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chemi·cal bonds. The single s orbital is spherically sym-
metrical with respect to the origin. The three £ orbitals 
have dumbbell shapes with each orbital oriented along one of 
the three axes and with the node of the dumbbells at the or-
igin. Four of the d orbitals have cloverleaf shapes; three 
are oriented in the xy, xz, and yz planes with their lobes 
situated between the axes and their nodes at the origin 
while the fourth has its lobes along the x and y axes with 
its node at the origin. The final d orbital has a dumbbell 
shape with a torus wrapped around the center; the dumbbell 
is oriented along the z axis with its node at the origin and 
the torus is in the xy plane. The set of orbitals of each 
sublevel are spherically symmetrical with respect to the 
nucleus. It is the fact that a symmetrical arrangement of 
electrons about the nucleus is energetically favorable that 
accounts for the stability of filled or half-filled sub-
shells. 
2. THE COORDINATE BOND (Basolo and Johnson, 1964; Basolo 
and Pearson, 1967) 
A coordination compound contains one or more coordi-
nate covalent bonds which are covalent bonds in which one of 
the two atoms involved supplies both of the electrons of the 
bond. The electron pair acceptor of the coordinate covalent 
bond is the central ion and is, typically, an ion of a metal 
with d orbitals. The coordinating groups, or ligands, are 
,. 
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ions or neutral molecules which are the electron pair donors 
in the formation of the coordinate covalent bond. The 
number of coordinate covalent bonds that can exist betwen 
the central ion and the ligands is the coordination number 
of the ion. 
Alfred Werner laid the foundation of modern structural 
inorganic chemistry when, in 1893, he proposed his coordi-
nation theory. The central principle of this theory, for 
which Werner won the 1913 Nobel Prize in Chemistry (Werner, 
1966), is that most elements have two types of valence, a 
primary valence corresponding to its oxidation state and a 
secondary valence corresponding to its coordination number. 
According to Sidgewick (1927) a central ion, having achieved 
a stable, non-noble gas electron configuration through 
oxidation will often surround itself with enough ligands 
that the tot'al number of electrons around the metal is the 
same as that in a noble gas. This concept is often useful 
in predicting the coordination number of a central metal 
ion. 
There are three theories that are used to explain the 
properties of coordination compounds. These three (the 
valence bond theory, the electrostatic theory, and the mo-
lecular orbital theory) differ in the manner in which they 
consider the approach of ligands to affect the central atom 
and its orbitals. However, all three theories qualitatively 
account for the main features of coordination complexes. 
Therefore, the theory that is the most convenient in the 
present application, the valence bond theory, will be 
discussed. 
Linus Pauling was awarded the 1954 Nobel Prize in 
Chemistry for developing his theory of chemical bonding 
(Pauling, 1966). According to his valence bond theory 
(Pauling, 1960) the number of orbitals on the central ion 
made available for the formation of coordinate covalent 
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bonds with orbitals on the ligands must equal the number of 
ligands. Since the strongest coordinate covalent bond is 
the result of maximum angular overlap of the two coordi-
nating orbitals, the coordinating atomic orbitals of the 
central metal atom must form hybrid orbitals, all of which 
are equivalent and have definite spatial arrangements. The 
geometry of the coordination complexes is established by the 
geometry of the hybrid orbitals. Thus, for example, if the 
coordination number is 2, 4, or 6 and the coordinating 
orbitals are one s and one£, one s and three £ 1 S, one d, 
one~· and two £ 1 S, or two d's, one~· and three £'S then 
the respective geometry of the coordinating orbitals and the 
resultant coordination compounds is linear (~ hybridiza-
tion), tetrahedral (~3 hybridization), square planar 
(dsp 2 hybridization) or octahedral Ci2sp3 hybridization). 
A cr bond is a coordinate covalent bond formed when a 
hybrid orbital accepts a pair of electrons from a ligand in 
such a manner that the electron density is symmetrical about 
,. 
the bond axis. A rr bond, on the other hand, has a minimal 
electron density about the bond axis and is formed if the 
central atom has loosely held d electrons and the ligand 
vacant d orbitals or vice versa. The rr bond strengthens 
the a bond and reduces the negative charge resulting from 
the addition of ligands to the central atom. 
3. THE HARD AND SOFT ACID AND BASE CLASSIFICATION OF 
LEWIS ACIDS 
G. N. Lewis (1923) defined a base as an atom, mole-
cule, or ion having at least one pair of unshared valence 
electrons. An acid was similarly defined as an atom, mole-
cule, or ion having a vacant orbital in which a pair of 
electrons can be accommodated. The typical Lewis acid-
base reaction is: 
A + 
acid 
:B 
base 
A:B 
acid-base complex. 
This generalized Lewis acid-base reaction is the most im-
portant of all classes of chemical reactions. 
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The Lewis acid-base concept classifies all metal ions 
as Lewis acids. Sidgewick (1927) noted that in a classical 
coordination complex the metal ion completes a stable elec-
tron configuration by accepting electron pairs from ligands. 
He, therefore, named Lewis acid-base reactions involving 
metal ions with vacant orbitals coordinate bond formation 
and coined the terms "acceptor" for the Lewis acid or 
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central metal ion and "donor" for the Lewis base or ligand. 
It follows that most metal ions tend to form coordination 
compounds but the tendency to do so generally increases 
with rising electron affinity of the metal. 
Lewis acids and bases have been classified by'Pearson 
(1968 a and b) into hard and soft acids and bases (HSAB) in 
order to provide a general explanation of the stability of 
the acid-base complex A:B. The HSAB principle provides a 
qualitative, or, at best, a semiquantitative rule. It does, 
nonetheless, have considerable utility, proving very useful 
in predicting which metal will combine most strongly with 
which ligand and in correlating and understanding the large 
amount of information presently available. 
Certain properties of the Lewis acid result in either 
a high electropositivity and low polarizability or low elec-
tropositivity and high polarizability. These are general 
criteria chosen by Pearson as the basis for the classifica-
tion of Lewis acids as hard or soft. Thus some Lewis acids 
are small, have a high positive oxidation state, and do not 
contain unshared electrons in their valence electron shells. 
These properties result in high electropositivity and low 
polarizability on the basis of which these Lewis acids are 
classified as hard. On the other hand some Lewis acids are 
large, have a low positive oxidation state, and contain 
several unshared electrons in their valence electron shell. 
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These properties result in low electropositivity and high 
polarizability as a result of which these Lewis acids are 
classified as soft. Borderline acids have intermediate 
properties hence behave like hard acids in the presence of 
hard bases and behave like soft acids in the presence of 
soft bases. Hard solvents, of which water is one of the 
hardest, will partially destroy hard acid characteristics 
and enhance soft acid characteristics. 
In a similar manner Pearson classified Lewis bases as 
hard or soft. Hard bases contain a donor atom of low polar-
izability and high electronegatively which is difficult to 
reduce and is associated with empty, high energy (hence in-
accessible) orbitals. In contrast, soft bases contain a 
donor atom of high polarizability and low electronegativity 
which is either easily oxidized or associated with empty, 
low-lying orbitals. 
Pearson formulated the principle of hard and soft 
acids and bases as a concise statement summing up the 
experimental data used to classify Lewis acids and bases as 
hard or soft. That principle states that the most stable 
complexes result from hard acid-hard base and soft acid-
soft base combinations. The type of bond usually associat-
ed with hard acid-hard base bond formation is typically 
ionic while that associated with soft acid-soft base bond 
formation is typically the covalent (cr) and, under appro-
priate conditions, the rr bond. 
·"La vie est dure" according to Pearson (1966). That 
.. 
is, ;hard acids and hard bases are the normal, abundant corn-
. ··: 
pone~t~ of b~ological systems. Most soft acids and soft 
bases·, o.n the other hand, are poisons to living organisms 
because t?ey form strong complexes with the soft bases and 
soft a'cids present in small amounts in the organism as the 
all important active centers of certain enzymes, etc. 
, 
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E. THE METAL ION AND ITS ROLE IN ENZY}ffi ACTIVITY 
1. THE ENZY}ffi (Kachmar and Moss, 1976; Lehninger, 1975) 
In 1897 Eduard Buchner discovered that sugar can be 
made to ferment not only with ordinary yeast but also with 
the help of the expressed juices of yeast which contain no 
yeast cells. The discovery of these unknown active sub-
stances called enzymes was so important that Buchner was 
awarded the 1907 Nobel Prize for Chemistry (Buchner, 1966). 
Wilhelm Ostwald received the 1909 Nobel Prize for Chemistry 
for formulating the basic principle of catalysis which says 
that a catalyst increases the rate at which a chemical re-
action occurs without itself being consumed or permanently 
altered (Ostwald, 1966). Ostwald was the first to point out 
that enzymes act as catalysts. It was not until 1926 when 
James B. Sumner crystallized the enzyme urease that enzymes 
were recognized as proteins. For this work Sumner was a-
warded the 1946 Nobel Prize for Chemistry (Sumner, 1966). 
It was later demonstrated that the way an enzyme increases 
the rate of a biological reaction is by providing a reaction 
route having a lower free energy of activation for the tran-
sition of substrate to product than the uncatalyzed re-
action. 
The specific catalytic activity of many enzymes de-
pends solely on the unique amino acid composition and 
sequence and the native conformation, or folded state, 
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determined by the interaction of amino acid side chains with 
each other and the solvent. Other enzymes, however, require 
in addition the presence of some nonprotein entities or co-
factors before enzyme activity can be manifested or max-
imized. If a cofactor is an organic substance it is 
referred to as a coenzyme while if it is an inorganic ion, 
such as a metal ion, it is called an activator. 
Enzymes are proteins hence heat, extremes of pH, and 
various chemicals, including metal ions, can alter their 
structure (i.e. denature them). Denaturation can be wholely 
or partially reversible or irreversible depending on the 
cause of the denaturation and its duration of action. Since 
the ability of an enzyme to catalyze a specific reaction is 
dependent on its unique amino acid composition and sequence 
and the precise conformation of the folded polypeptide that 
they determine, even slight denaturation can render it 
inactive. 
2. THE SULFHYDRYL GROUP AND ENZYME INHIBITION 
Sulfhydryl groups (-SH) are chemically the most 
active groups found in cells. As such they react as a class 
specifically and often quantitatively with various thiol-
combining agents including a wide range of metal ions with 
which they form stable complexes (Jocelyn, 1972). The 
reactivity of sulfhydryl groups is due to the fact that they 
dissociate to mercaptide ions ( RS-) in aqueous media 
p 
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which are 500 times more nucleophilic that the correspond-
ing oxygen analogue ( RO-) (Streitweiser, 1956). Among 
factors contributing to the nucleophilicity of the mer-
captide group is the ease with which its negative charge and 
unshared electrons can be polarized and attracted by elec-
trophilic centers. Thus sulfhydryl groups, especially 
sulfhydryl groups in aqueous media, are soft Lewis bases. 
In many enzymes the presence of free cysteine sulf-
hydryl groups is essential for activity. Boyer (1959) pro-
vided a general definition of a sulfhydryl enzyme as an 
enzyme that loses its catalytic activity when some or all of 
its original sulfhydryl groups are chemically modified. 
These, like nearly all sulfhydryl proteins, occur intra-
cellularly and are less stable than disulfide proteins due 
to the absence of covalent cross links hence they can usual-
ly be denatured under mild conditions (Cecil, 1963). In 
vitro oxidation of these groups to disulfide groups (-S-S-) 
by dissolved oxygen at neutral and alkaline pH is a typical 
example of this. Often, however, an enzyme denatured in 
this manner can be reactivated by treatment with thiols 
such as cysteine, mercaptoethanol, dithiothreitol, or re-
duced glutathione which reduce disulfide bridges to the 
free -SH form through a thiol-disulfide interchange 
(Haschemeyer and Haschemeyer, 1973). 
Sulfhydryl groups within many enzymes vary in re-
activity toward various reagents. The reactivity 
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differences of -SH groups of different enzymes and even with-
in the same enzyme molecule is related to their functional 
roles as essential catalytic sites in substrate binding and 
maintaining protein structure and conformation. However, 
Friedman (1973), after reviewing the literature on more than 
40 sulfhydryl enzymes, concluded that the evidence indicat-
ing whether the -SH groups of -SH enzymes participate direct-
ly in catalysis by, for example, interacting with electro-
philic centers of substrates or by maintaining an enzyme con-
formation required for activity is equivocal. The mechanism 
is difficult to deduce from current techniques of chemically 
modifying essential -SH groups because substrate reactions 
could be sterically hindered by conformational changes near 
the reactive site as easily as they could by a chemical 
change in the site itself (Spradlin and Thoma, 1970). 
Paul Ehrlich received the 1908 Nobel Prize in Phy-
siology or Medicine for his studies on the relation be-
tween toxins and antibodies (Ehrlich, 1967) which resulted 
in his well-known side-chain theory, the foundation of 
modern receptor theory. An important conclusion reached by 
Ehrlich (1909) as a result of this work was that sulfhydryl 
groups act as receptors for metal ions. Voegtlin and co-
workers (1924) later proved this and also demonstrated that 
thiols could counteract the toxic effect of metal ions by a 
thiol-mercaptide interchange. 
Reactions leading to metal mercaptide formation are 
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among the most specific of the varied reactions of the sulf-
hydryl group (Boyer, 1959). In most instances when metal 
ions are found to inhibit enzymatic activity reaction with 
sulfhydryl groups is the first suspected. Divalent lead, 
copper, mercury, cadmium, and zinc and monovalent silver, 
all soft or borderline Lewis acids, are those metal cations 
most likely to inhibit enzyme activity through the formation 
of monodentate metal mercaptides with the sulfhydryl groups 
of the cysteine residues of a large number of enzymes 
(Vallee and Wacker, 1970). The marked affinity of certain 
metal cations for RS is a result of their tendency to ac-
cept electrons in a coordinate covalent bond together with 
the willingness of RS to donate electrons. In addition, ~­
type bonding with sulfur can occur through overlap involving 
d orbitals (Liu, 1977). The relative magnitude of enzyme 
inhibition due to the interaction of metal ions with free 
sulfhydryl groups is generally proportional to the solu-
bility products of the metal sulfides (Klotz, 1954). 
3 . THE METALLOENZYME AND THE METAL-ENZYME COMPLEX 
According to Vallee and Wacker (1970) nearly one third 
of all enzymes have metals built into their structure, re-
quire added metal for activity, or are further activated by 
metal ions. In 1955 Vallee defined metalloenzymes as en-
zymes which retain stoichiometric, tightly bound, functional 
metal ions when purified while a metal-activated enzyme was 
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defined as one to which metal ions had to be added for acti-
vity. Malmstrom and Rosenberg (1959) pointed out the fact 
that the major difference between metalloenzymes and metal-
enzyme complexes is a quantitative one; in metal-activated 
enzymes the affinity for the metal ion is relatively low 
but the role of the metal ion might be the same as in metal-
loenzymes in which the affinity of the enzyme for the metal 
is relatively high. The rough dividing line between metal-
loenzymes and metal-activated enzymes is a stability con-
stant of 108 M-l (Coleman and Vallee, 1961). Borderline 
cases do exist in which an enzyme partially retains the 
metal activator on purification but an increase in the re-
sidual activity is observed upon the addition of metal ions 
to the purified enzyme. 
The same metal ion may fill several different roles 
in the same enzyme and different metal ions may also have 
different roles in the same enzyme. The structural role, 
the nature of the ligand, the geometry of the complexes 
which produce the effects and their relevence to protein 
conformation are sketchy and cannot be categorized with 
certainty due to a lack of adequately sensitive experi-
mental approaches. 
According to Vallee and Wacker (1970) it is possible 
for a metal ion to affect enzyme activity by: 
a. ·participating in binding substrates, cofactors, 
or both 
b. activating the enzyme-substrate complex once it is 
formed 
c. serving both functions 
d. maintaining secondary, tertiary, or quarternary 
structure or interacting with the side chains in 
such a manner that the resulting coordination com-
plex can function catalytically 
e. undergoing oxidation-reduction during the enzyme 
reaction, transferring electrons in oxidative pro-
cesses 
f. bringing about changes in conformation that are 
either functionally or structurally advantageous 
or both 
g. putting the enzyme in a state of entasis, consti-
tuting an energetically poised domain. 
For most enzymes the available information does not allow 
a detailed microscopic differentiation of these possibili-
ties. 
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In their review of the field Vallee and Coleman (1964) 
observed that the metals involved in these enzymatic re-
+2 actions are limited to the alkaline earths, Ca and 
Mg+2 , the metals of the second half of the first transi-
tion period, the Group IIB metals, and a single metal from 
the second transition period, molybedenum. There is, ac-
cording to these authors, no preferred distribution of 
metals among the various enzyme catalyzed reactions except 
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for molybdenum and copper. Molybdenum is encountered ex-
clusively in the metalloflavoproteins and copper enzymes 
catalyze a series of oxidation-reduction reactions without 
the aid of additional cofactors but copper is not an essen-
tial participant in hydrolytic systems. The alkaline earths 
and manganese activate a large number of enzyme systems in-
volving ATP and in many of these instances the first tran-
sition metals can also activate. Zinc plays a varied role 
in metal-enzyme catalyzed reactions, occurring in each of 
the six categories of enzymes designated by the Internation-
al Union on Biochemistry (IUB) commission on enzymes which 
are oxidoreductases (e.g. human liver alcohol dehydrogenase; 
Von Wartburg et al., 1964), transferases (e.g. ~· coli DNA 
polymerase; Slater et al., 1971), hydrolases (e.g. human 
leukocyte alkaline phosphatase; Trubowitz et al., 1961), 
lyases (e.g. human erythrocyte carbonic anhydrase; Rickli 
and Edsall, 1962), isomerases (e.g. brewer's yeast mannose-
6-phosphate isomerase; Gracy and Noltmann, 1968), and li-
gases (e.g. yeast pyruvate carboxylase; Scrutton et al., 
1970). 
The number of side chain functions of proteins (in-
cluding carboxyl, imidazole, and sulfhydryl functions) , of 
course, greatly exceeds the number of terminal groups so 
these are the important metal binding sites. There are 
always more than are actually needed so each metal ion may 
choose which site it prefers on a HSAB basis, the general 
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relationship between protein donor atom and the metal pre-
ferring it being: 
-0 :N, -0 :N, -S -s 
Ca, Mg, Mn Fe, Co, Ni Cu, Zn Cd, Pb, Ag, Hg 
The choice of ligand is also determined by factors affecting 
the local environment of the ligand including intra- or 
inter-molecular hydrogen bonding, electrostatic or hydro-
phobic interactions, the vicinal effects of charges, and the 
stereochemistry of the ligand and the enzyme of which it is 
a part. Different metal ions can and do combine with the 
same ligand of a given enzyme but their different geome-
tries could activate the enzyme by providing a three dimen-
sional template or inhibit the enzyme by failing to provide 
such a template or disrupting the three dimensional struc-
ture of the enzyme. (Vallee and Williams, 1968; Williams 
1971) 
4. THE INTERACTIONS OF METAL IONS IN BIOLOGICAL SYSTEMS 
As one considers the trace element requirements of 
man and animals numerous interrelationships between es-
sential minerals as well as between essential and non-
essential minerals are noted. A number of trace element 
deficiencies arise or are induced by biological interactions 
among these minerals. A trace element deficiency results 
from a failure in the supply of an essential nutrient to at 
least one of its functional sites. When the deficiency is 
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induced by the presence of antagonists the interaction may 
occur at any of these essential loci during gastrointes-
tinal absorption and during incorporation into binding sites 
of enzymes and transport, storage, and cellular structural 
proteins. Hill and Matrone (1970) have proposed an explana-
tion for these relationships based on the electronic confi-
guration of the ionic form of the minerals. Their hypothe-
sis is that "Those elements whose physical and chemical 
properties are similar will act antagonistically to each 
other biologically." The interactions of such elements are, 
therefore, competitive and, as such, negative and mutual. 
Thus the effects of an excessive concentration of an antag-
onistic element, essential or nonessential, is reversible 
if the concentration of the agonist is increased (Bremner, 
1974). 
There are antagonistic relationships between the ions 
of certain elements which have electronic structures that 
are not at all similar. Such noncompetitive interactions 
arise when an excess or deficiency of an element influences 
the metabolic fate of a second element or interferes with 
some biological process essential for the full expression 
of its biological activity. This may happen by the excess 
or deficiency of an element inducing or failing to induce 
the synthesis of a protein to which the second element binds 
or by the excess of a given element forming an insoluble, 
nonavailable complex with the second element. Such 
ll 
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interactions are generally discovered by empirical obser-
vation hence there exist no rules concerning reversibility, 
mutuality, or the negative or positive nature of the 
interaction. (Davies, 1974) 
The present evidence for a direct competition within 
the gastrointestinal tract for binding sites in the trans-
fer of minerals across intestinal membranes is limited. To 
be sure, in the presence of abnormally high levels of one 
element and marginal levels of another indirect competition 
through the formation of insoluble complexes, a change in 
solubility as a result of hydrogen ion concentration, or a 
change in the microflora of the gastrointestinal tract with 
the consequent sequestering of essential elements can be 
crucial. Nonetheless, it does seem more likely that absorp-
tion competition is minimal when compared with competition 
at sites within the body tissues (Davis, 1972). 
While similar ions are always antagonistic in vivo 
they often show interchangeability in the activation of 
certain enzymes in vitro (Matrone, 1970; Vallee and Coleman, 
1964). An important area of future research is the identi-
fication, in vivo, of synergistic interactions among the 
elements as well as the substitution of closely related 
metals in enzyme structures with a consequent change in 
enzymatic activity. 
CHAPTER II 
RESEARCH OBJECTIVES 
CHAPTER II 
RESEARCH OBJECTIVES 
The purpose of the research described and discussed 
in this dissertation was the determination of factors 
associated with or affecting an increase or decrease in 
mammalian erythrocytic ALAD activity. 
The initial objective of the present research was to 
determine whether a linear relationship exists between the 
degree of reticulocytosis and erythrocytic ALAD activity in 
the developing male rat. This seemed of particular interest 
because ALAD activity is often used as an index of the 
degree of experimental lead intoxication in the rat. A 
variation of ALAD activity with the age of the animal and 
the reticulocytosis present at that age would be an impor-
tant source of variability in lead poisoning analysis. 
Furthermore, if such a relationship does exist this study 
might serve to establish the developing rat as a useful 
model in which to further investigate whether a decrease in 
the activity of the soluble cytoplasmic enzyme with the age 
of the red cell is due to a denaturation of the enzyme pro-
tein, a decreased concentration of an enzyme activator, or 
an increased concentration of an enzyme inhibitor. 
It then seemed necessary to establish a reference 
value for the erythrocytic ALAD activity of normal, healthy, 
nonmedicated adult male and female volunteers and to 
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determine whether the enzyme activity could be correlated 
with gender, age, or reticulocyte percent. ~fuile this would 
add to the present knowledge that both lead and genetic 
factors influence the level of erythrocytic ALAD activity, 
its main purpose was to establish a screen of the enzymatic 
activity of normal adult human volunteers used in the main 
section of the present study. 
Finally, this research sought to establish a dose-
response curve for the in vitro lead-induced inhibition of 
normal adult human erythrocytic ALAD and for the activation 
of the enzyme by a metal ion discovered on screening various 
potential activators. It was, therefore, the main purpose 
of this study to determine, in a dose-response fashion, the 
in vitro effects of the soluble acetate, chloride, or 
fluoride salts of Na+, Mg+Z, Al+3 , ~fu+Z, Cu+2 , Ag+ Zn+2 , 
H +2 G +3 g ' a ' I 
+3 
n ' 
enzyme and on an enzyme 
Pb+2 , Sn+2 , and Sn+4 on the normal 
50% inhibited by Pb+Z while at the 
same time examining the ability of a maximally stimulatory 
concentration of the activator metal ion to prevent or re-
verse the effects of these other metal ions. The effects of 
these metal ions were then classified in terms of their oxi-
dation state, valence electronic configuration, characteris-
tic coordination number, coordination geometry, and hard and 
soft Lewis acid characteristics in order to determine what 
physical and chemical properties are associated with the 
ability of a metal ion to activate or inhibit erythrocytic 
---
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ALAD and whether these properties are unique to any 
single metal ion. This could serve to establish the basis 
of a future investigation of the actual metal ion require-
ment of human erythrocytic ALAD as well as of a potential 
prophylactic and therapeutic use of nontoxic metal salts in 
the prevention and treatment of both pediatric and adult 
lead poisoning. 
CHAPTER III 
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CHAPTER III 
HATERIALS AND METHODS 
A. THE WHOLE BLOOD SPECIMEN 
1. THE ANIMALS 
Male Sprague-Dawley rats were obtained from the 
Holtzman Rat Company (}fudison, Wise.), rats less than 20 
days of age being sent and housed with a nursing dam. Rats 
more than 20 days old were housed no more than 5 animals per 
mesh-bottomed stainless steel cage and fed Purina Rat Chow 
(St. Louis) ad libitum with uninterrupted access to water. 
Animals were maintained in a temperature controlled (22°C) 
room under a 12 hour light: 12 hour dark schedule (lights on 
0700-1900 hours). 
Following ether (Mallinckrodt, St. Louis) anesthesia, 
blood was obtained from rats aged 20 days and older by 
aortic puncture using a sodium heparinized Vacutainer tube 
and an appropriate modification of the technique described 
below. Blood was obtained from younger rats by decapitation 
and allowing the blood to drop into a similar Vacutainer 
tube. A complete blood count and reticulocyte percent were 
determined for each blood specimen as described below. 
2. THE H~AN VOLUNTEERS 
Blood was obtained from normal, healthy, nonmedicated 
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adult male and female volunteers, after obtaining informed 
consent, by cubital venipuncture into sodium heparinized 
Vacutainer tubes as described below. When establishing 
normal reference values for adult human ~rythrocytic ALAD 
activity, volunteers from 18 to 70 years of age were used. 
For the metal ion activation and inhibition studies, blood 
was obtained from an equal number of male and female volun-
teers between the ages of 18 and 30. As a routine screen 
of the volunteers, a complete blood count and reticulocyte 
percent were determined for each of the volunteers' blood 
specimens as described below. 
3. THE ROUTINE VENIPUNCTURE (Miale, 1977) 
All equipment used for the routine venipuncture was 
dry and sterile. A tourniquet was applied to the arm of the 
volunteer above the elbow just tight enough to prevent the 
venous return. The area over the cubital vein was cleansed 
by wiping vigorously for one minute with an alcohol wipe 
(Will Ross, Milwaukee) and allowed to air dry. A 5 ml 
heparinized (132 units of sodium heparin) B-D Vacutainer 
tube (3206 KA; Becton, Dickinson and Co., Rutherford, N.J.) 
was affixed to the adaptor-held 21 gauge/1 inch multidraw 
needle (Safe II; Jelco, Raritan, N.J.) so the innermost 
shaft of the needle held the stoppered tube in place but did 
not penetrate the stopper. The sheath was removed from the 
needle and the vein entered with the bevel of the needle up 
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and, with the adaptor held firmly, the Vacutainer tube was 
forced onto the needle shaft so the rubber stopper was 
penetrated and the blood flowed into the tube. When the 
tube was filled to capacity the tourniquet was released, the 
tube was removed from the needle shaft, and the needle was 
withdrawn from the vein. The tube was then gently inverted 
several times to allow thorough mixing of the blood with the 
anticoagulant, pressure was applied to the site of the veni-
puncture with a gauze square, and the arm of the volunteer 
was elevated to assist in collapsing the punctured vein. 
B. THE HEMATOLOGIC PROFILE 
1. THE MICROHEMATOCRIT 
Microhematocrits (Hct) were determined in duplicate 
using an adaption of the method of Strumia et al. (1954). 
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A plain capillary tube was filled by capillary action approx-
imately two thirds full with an aliquot of heparinized whole 
blood and one end sealed with sealing clay. The tubes were 
then placed in opposite radial groves of an International 
micro-capillary centrifuge, Model MB (International Equip-
ment Company, Needham Hts., Mass.), with the sealed end out 
against the rubber liner, the centrifuge cover put in place, 
and centrifuged at 11,500 revolutions per minute. The 
hematocrit was then read on an International micro-capillary 
reader. Because the hematocrit measured in this manner in-
cludes trapped plasma it is higher than that determined by 
calculation on the Coulter Counter Model S but the amount of 
plasma trapping in normal subjects is only 3% (England et 
al., 1972). 
2. THE COMPLETE BLOOD COUNT 
The complete blood count (CBC), which includes the 
hemoglobin (Hb), hematocrit (Hct), red blood cell count, 
mean corpuscular volume (MCV) , mean corpuscular hemoglobin 
(MCH), mean corpuscular hemoglobin concentration (MCHC), and 
white blood cell count, was determined on heparinized whole 
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blood using the Coulter Counter Model S (Coulter Electronics, 
Hialeah, Fla.) as described and assessed by Pinkerton and 
co-workers (1970). This instrument consists, in effect, of 
three Coulter counters electronically counting and sizing 
red cells and three electronically counting white cells 
together with a photosensitive device for measuring Hb con-
centration as cyanmethemoglobin. From the Hb, red cell 
count, and MCV, which it measures directly on 44.7 ~1 of 
whole blood appropriately diluted by the instrument, the 
Coulter Counter Model S electronically calculates the Hct, 
MCH, and MCHC using the following relationships: 
Hct = 
MCH = 
MCHC = 
MCV x red blood cell count 
10 
Hb X 10 
red blood cell count 
Hb X 100 
Hct 
The precision and accuracy of the results obtained with the 
Coulter Counter ~1odel S are reported to be much better than 
that of careful manual estimates and at least comparable to 
that of other automated equipment. 
3. THE RETICULOCYTE COUNT 
The new methylene blue method for staining reticulo-
cytes (Brecher, 1949) was employed. The staining solution 
consisted of 0.5 g of the supravital stain new methylene 
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blue Nand 1.6 g of potassium oxalate (which acts as an anti-
coagulant and makes the staining solution isotonic) (Harleco, 
Gibbstown, N.J.) dissolved in 100.0 ml of distilled water. 
The solution was filtered before use. 
Approximately 100 ~1 each of staining solution and 
fresh or heparinized whole blood were mixed in a small cup 
and allowed to stand for 20 minutes. After staining, thin 
smears were made and allowed to air dry before counting. 
The number of reticulocytes encountered while 1000 
erythrocytes were examined under oil immersion was then 
determined. A reticulocyte was considered to be any erythro-
cyte containing two or more granular or reticulum-like 
inclusions with the appropriate staining characteristics 
since one cannot be certain a single refractile blue gran-
ule is a remnant of reticulum (Seip, 1953). The number of 
reticulocytes counted in this manner divided by 10 was taken 
to be the percent of reticulocytes present. 
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C. THE DETEru1INATION OF ERYTHROCYTIC ALAD ACTIVITY 
1. THE BASIC ALAD ASSAY 
All current in vitro assays for erythrocytic ALAD are 
based on the properties of the enzyme described by Gibson et 
al. (1955) and Granick and Mauzerall (1958b). Bonsignore 
and associates (1965) developed the first clinically useful 
test for erythrocytic ALAD activity because they demonstrat-
ed that it is not necessary to conduct the assay either 
under nitrogen or in vacuo and it is not necessary to wash 
the red cells. This method was subsequently modified by 
Weissberg and associates (1971) who conducted the assay on 
micro samples of blood and by Burch and Siegel (1971) who 
introduced a more stable buffer. Erythrocytic ALAD was 
determined in the present study using an adaptation of the 
whole blood micro-methods of Weissberg et al. (1971) and 
Burch and Siegel (1971) (FIGURE 2) . 
A 0.1 ml aliquot of heparinized whole blood, drawn 
into a 100 ~1 disposable micropipet, was.hemolyzed in 1.5 ml 
of aqeous 0.2% Triton X-100 (cetyl phenoxy polyethoxyethanol; 
Sigma, St. Louis). The hemolysate was ·warmed to 37°C for 
5 minutes following which 1.0 ml of freshly prepared 0.01 M 
ALA"HCl (Sigma) in 0.25 M dibasic sodium phosphate heptahy-
drate (Mallinckrodt)/citric acid (Fisher, Fair Lawn, N.J.) 
buffer. At the end of a 1 hour incubation at 37°C the 
reaction was stopped by the addition of 1.0 ml of a 10% 
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trichloroacetic acid (Mallinckrodt) solution which also con-
tained 0.02 M N-ethyl maleimide (Sigma) followed by the 
immediate addition of 0.05 ml of a saturated cupric sulfate 
pentahydrate (Baker, Phillipsburg, N.J.) solution. After 
standing for 5 minutes the mixture was centrifuged at 
600 x g for 10 minutes at room temperature. A 2.0 ml 
aliquot of the supernatant was withdrawn and 2.0 ml of fresh 
Ehrlich's reagent, prepared as described below, was added. 
After 15 minutes the optical density was read at 555 nm 
using a 1.0 em light path cuvet in a Bausch and Lomb Spec-
tronic 20 colorimeter (Rochester, N.Y.) set to 100% trans-
mission with a reagent blank in which water was substituted 
for blood since the absorbance of a blank is negligible com-
pared to that of a reagent blank. 
A milliunit (mU) of erythrocytic ALAD activity is de-
fined (FIGURE 3) as the amount of enzyme that will catalyze 
the transformation of 1 nH of PJ.....A to PBG per minute at pH 
6.7 and 37°C. Erythrocytic PJ.....AD activity is expressed as 
mU/ml of packed red blood cells and was defined by the 
following formula: 
ALAD mU/ml RBC = on60 x (100/Hct) x 40.56 
where: 
on60 = the optical density after incubation of the 
hemolysate with the substrate for 1 hour at 
37°C 
Ret = the microhematocrit determined as described above 
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40.56 = (3.65 x 2) (the blood dilution) 
0.1 (the blood volume) x 60 (the incubation time) 
1 
X 
0.060 (the optical density of 1 nM of PBG/ml) 
x 2 (2 molecules of ALA yield 1 molecule of PBG). 
The PBG extinction coefficient determined under these experi-
mental conditions is in exact agreement with that described 
in the literature (Mauzerall and Granick, 1956; Burch and 
Siegel, 1971). 
Triton X-100 is a non-ionic surfactant (soluble amphi-
phile) that, at the concentration used in the present study, 
ensures immediate and complete lysis of the erythrocytes. 
While the molecular mechanism of lysis is unknown, the lytic 
process is known to consist of five steps: 
a. the surfactant adsorbs to the cell membrane 
b. the surfactant penetrates into the cell membrane 
c. the surfactant induces a change in the molecular 
organization of the cell membrane 
d. the change in molecular organization results in 
a change in the permeability of the cell membrane 
and a consequent change in the osmotic equilibrium 
across the cell membrane 
e. once the osmotic equilibrium is sufficiently offset 
and proteins and other macromolecules begin to pass 
through the membrane lysis has occurred. 
jiP' 
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Triton X-100, however, does not induce conformational 
changes in soluble cytoplasmic proteins leading to a loss of 
their biological properties hence is safe to use for lysis 
of erythrocyte membranes so the activity of a soluble cyto-
plasmic enzyme (such as ALAD) can be studied. (Helenius and 
Simons, 1975) Mitchell and co-investigators (1977) found 
that results obtained on erythrocytes hemolyzed in 0.2% 
Triton X-100 are not significantly different than results 
obtained on freeze-thaw hemolyzed erythrocytes. 
The bicarbonate buffered ALA substrate prepared accord-
ing to the method of Bonsignore and associates (1965) does 
not provide adequate buffering capacity, the pH increasing 
from an initial pH of 7.0 to a final pH of 8.2 after 1 hour 
of incubation (Burch and Siegel, 1971; Finelli et al., 1974), 
thus could not be used. In addition, the use of potassium 
ions in the buffer (as in all other reagents) had to be care-
fully avoided since K+ reacts with perchloric acid in the 
modified Ehrlich's reagent resulting in the formation of a 
very fine potassium perchlorate precipitate which can inter-
fere with the assay by falsely elevating the absorbance 
readings (Finelli et al., 1974) unless removed by low-speed 
centrifugation (Mitchell et al., 1977). Therefore the buf-
fer employed was an extremely stable 0.25 M dibasic sodium 
phosphate heptahydrate/citrate buffer which maintained the 
pH of the incubation mixture at the optimum pH found for the 
normal enzyme, 6.70 ± 0.05 (Burch and Siegel, 1971) even 
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when very large concentrations of metal ions were added 
(Hitchell et al., 1977). Furthermore, although phosphates 
often form insoluble salts with metal cations, the phosphate 
used in the present buffer system does not interfere with 
the determination of erythrocytic ALAD activity even when 
-2 the metal ions are added up to a concentration of 10 M 
(Mitchell et al., 1977). 
In the determination of erthrocytic ALAD activity the 
product of the action of ALAD, PBG, is measured colormetri-
cally. In the color reaction PBG condenses at its unsubsti-
tuted a: position in acidic solution w·ith D¥..AB, which is 
present is large excess, to form a colored condensation 
product, rnonopyrrylphenylrnethane, the intensity of which 
increases rapidly and diminishes slowly. The color salt can 
further react with another molecule of PBG to form a color-
less dipyrrlphenylrnethane but with excess DMAB this reaction 
is very slow. (Mauzerall and Granick, 1956) Sulfhydryl corn-
pounds decolorize the pink salt formed by the reaction of 
the Ehrlich's reagent with PBG (Granick and Hauzerall, 1958b). 
Sulfhydryl interference can be prevented by tying up the 
sulfhydryl groups with N-ethyl rnaleirnide (Burch and Siegel, 
1971) or Cu+2 (Gibson et al., 1955); in the present pro-
cedure both of these methods of removing sulfhydryl inter-
ference were employed. 
Fresh Ehrlich's reagent was prepared in the following 
manner (Davis and Andelman, 1967; Davis et al., 1968; 
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Bio-Rad, 1968): 10 g of p-dimethylaminobenzaldehyde (DMAB; 
MCB, Norwood, Ohio) was added to 420 ml of glacial acetic 
acid (Mallinckrodt). This mixture is stable for several 
months when kept in a refrigerator at 4°C where it will 
solidify. Subsequent thawing on the day of the analysis 
was performed by running warm water over the outside of the 
bottle containing the acetic acid solution containing the 
added DMAB following which 19 ml of 72% perchloric acid 
(Mallinckrodt) was added to every 100 ml aliquot of the 
acetic acid solution containing the added DMAB. 
2. THE DETERMINATION OF THE EFFECT OF METAL IONS ON ERYTHRO-
CYTIC ALAD ACTIVITY 
The effects of various metal ions, alone and in com-
binations, on erythrocytic ALAD were studied (FIGURE 4). 
The metal ions were added by substituting an 0.1 ml aliquot 
of a freshly prepared solution of a given concentration of 
the metal ion to be studied for 0.1 ml of the 1.5 ml of 
aqueous 0.2% Triton X-100 solution in which the whole blood 
was hemolyzed. Soluble acetate, chloride, or fluoride salts 
of the metal ions were used after all effects of the acetate, 
chloride, and fluoride ions on erythrocytic ALAD activity 
were ruled out. The solutions were prepared in aqueous 0.2% 
Triton X-100 unless flocculation was observed in which case 
they were prepared in water. The 0.1 ml aliquots were added 
immediately after the 5 minute preincubation period or, in 
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the case of the preincubation studies to be discussed below, 
before or after the extended preincubation periods. When 
added in combination an ion being studied for its ability to 
activate ALAD was always added after an ion known to inhibit 
ALAD while an ion being studied for its ability to inhibit 
ALAD was always added before an ion known to activate ALAD. 
Several metal ions were initally screened for their 
effect on human erythrocytic ALAD over a wide concentration 
range and, as discussed below, Pb+Z was identified as an in-
hibitor of ALAD and zn+2 was identified as an activator of 
ALAD. The remaining ions were screened, over a broad con-
centration range, for their effect on the normal enzyme and 
on an enzyme preparation 50% inhibitied by lead (the In50 
Pb+Z concentration). In addition, that concentration of 
zn+2 able to maximally stimulate the enzyme (the sn100 zn+
2 
concentration) was examined for its ability to prevent or 
reverse the possible inhibition caused by the metal ions 
being studied. 
In order to further investigate the effects of several 
metal ions of interest preincubation studies were conducted. 
Solutions of the metal salts were added to hemolysates imme-
diately before or after preincubation periods of 0.5, 1.0, 
2.0, and 4.0 hours in order to determine if the observed 
effect of the metal ion was potentiated, unchanged, or 
reversed by prolonged exposure of the enzyme to the cation. 
Insofar as it was possible, all studies were conducted 
in such a manner that paired data could be gathered. That 
is, for a given blood sample the control ALAD activity ~vas 
determined for the normal enzyme and, as appropriate, for 
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the enzyme 50% inhibited by Pb+Z and maximally stimulated by 
Zn+Z at the same time the effect of metal ions on the normal, 
Pb+2-inhibited, and Zn+2-stimulated ALAD was being deter-
mined on other aliquots of the same blood specimen. All 
data was expressed as a percent of the normal, uninhibited, 
unstimulated, nonpreincubated erythrocytic ALAD activity for 
that specimen but statistical comparisons were made only on 
raw erythrocytic ALAD activities. 
All metal salts used were American Chemical Society 
approved analytical reagents whenever these were commercial-
ly available as were all other reagents. Distilled water 
was used in the preparation of these and all other aqueous 
solutions. The metal salts employed were: 
Na(CH3COO) '3 H2o (Mallinckrodt) 
NaCl (Baker) 
NaF (MCB) 
Mg(CH3COO)z'4 HzO (MCB) 
Alc1 3 ·6 H2o (Mallinckrodt) 
Mn(CH3COO)z'4 H2o (HCB) 
Cu(CH3coo) 2 ·H2o (Mallinckrodt) 
Ag(CH3COO) (HCB) 
Zn(CH3C00) 2 ·z H2o (Mallinckrodt) 
Cd(CH3C00) 2 ·z H2o (MCB) 
Cdc1 2 ·2~ H2o (Mallinckrodt) 
HgC12 (Mallinckrodt) 
GaC1 3 (Apache, Rockford, Ill.,) 
InC13 (K & K, Plainview, N.J.) 
SnF2 (Alfa, Danvers, Mass.) 
snc14·s H2o (Mallinckrodt) 
Pb(CH3COO)z"3 H20 (Baker). 
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D. THE STATISTICAL ANALYSIS 
Standard statistical methods were used to determine 
means, standard deviations, standard errors, nonpaired or 
Student's t values, paired t values, slopes, intercepts, and 
correlation coefficients (Goldstein, 1964; Sokol and Rohlf, 
1969). 
1. THE MEAN, STANDARD DEVIATION, AND STANDARD ERROR 
A statistic of location describes the position of a 
sample along a given dimension representing a variable; such 
a statistic is, therefore, a measure of central tendency and 
will yield a representative value for the sample of obser-
vations. The arithmetic mean, commonly referred to as the 
mean or average (x), is the most important statistic of 
location. The mean was calculated using the following 
formula: 
where: 
n 
x = Z: x. /n 
i=l ~ 
n = the total number of observations 
n 
~ = the sum of the observed values from the first 
i=l 
observation through the last. 
A statistic of location alone does not completely 
describe the shape of a frequency distribution; this is done 
by a statistic of dispersion. The standard deviation, s, 
is the statistic most commonly employed for describing 
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dispersion in the same units as those of the mean. The 
standard deviation is the distance measured along the x-axis 
from the center of the normal distribution curve (the mean) 
to the point of inflection of the curve which is its steep-
est point. The area under the curve at this distance mea-
sured on either side of the mean (i.e. x ± s) represents 
69% of the area of the curve while x ~ 1.96 s represents 
- + 95% of the area and x - 2.58 s represents 99% of the area. 
The standard deviation was calculated using the following 
formula: 
s = 
n 
- 2 k ( 2: (x. -x) I (n-1)) 2 
0 1 1. 1.= 
where: 
n - 2 ~ (xi-x) = the sum of the squares of the deviations 
i=l 
of all of the observed values from the 
mean of the observations. 
The standard error of the mean or the standard error, 
s- is the standard deviation of the sample means and is X' 
therefore a measure of the reliability of the estimated mean. 
It was calculated using this relationship: 
k 
s-=s/(n) 2 
X 
2. THE NON-PAIRED OR STUDENT'S t-TEST 
When one wishes to determine whether or not two sample 
means come from the same population one begins with the null 
hypothesis and assumes both samples are indeed drawn from 
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the same population. The hypothesis is rejected if the 
sample means differ from each other more than random sam-
pling variations would lead one to predict, assuming vari-
ances to be homogeneous. To this end the non-paired or 
Student's t-test was performed which compares the magnitude 
of the observed difference between sample means with an 
estimate of its standard error using the formula: 
where: 
-
xl 
-
x2 
= 
= 
t = (x1-x2)/s<- - ) xl-x2 
the mean of sample 1 
the mean of sample 2 
s(x1-x2) =the estimate of the standard error of the 
difference between sample means 
= (s 2 ((1/n1)+(1/n2 )))~ 
2 nl - 2 
s = ( ~ (x1 . -x1) + . 1 ~ ~= 
= the pooled variance estimate 
n 1 = the total number of observations in sample 1 
n 2 = the total number of observations in sample 2 
and a table of critical values of t was entered w·ith ( (n1-l) 
+ (n2-l)) degrees of freedom for the two-tail test. 
3. THE PAIRED t-TEST 
When two samples of data are obtained on the same sub-
jects, the variability due to differences between subjects 
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is eliminated and one considers only the difference in the 
response of the subjects to a treatment. The paired t-test 
tests whether the mean of sample differences between pairs 
of readings is significantly different from a hypothetical 
mean, which the null hypothesis establishes as zero. The 
paired t value was determined using the following relation-
ship: 
where: 
a = the mean difference between the paired observations 
sa = the standard error of the mean difference, a 
and a table of critical values of t was entered with (n-1) 
degrees of freedom for a one-tail test since the hypothesis 
about a treatment effect specifies its direction, 
where: 
n = the total number of paired observations. 
4. THE LINEAR REGRESSION AND CORRELATION COEFFICIENT 
The equation of a straight line is: 
y=mx+b 
where: 
m = the slope of the line or, in a linear regression 
analysis, the regression coefficient 
b = the intercept on the y-axis. 
The object of a linear regression analysis is to choose, as 
a best estimate, a "least squares" line for the data points 
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by establishing a line from which the sum of the squared 
deviations of the observed y and the predicted y are minimal. 
To this end the slope was calculated using this formula: 
m= 
n 
n L(xi) 
~ x.y. - i=l 
. 1 ~ ~ ~= 
n 
n 
~ (yi) 
i=l 
n 2 n 2 2:: x -. ( ~ x) /n 
i=l i=l 
and the y-intercept was calculated using the formula: 
b = 
n n 
2:_y. -m~x . 
. 1 ~ . 1 ~ ~= ~= 
n 
To determine whether or not a linear correlation 
between two variables x and y is strong or weak one calcu-
lates the correlation coefficient, r. For this purpose the 
following formula was employed: 
where: 
s = the X 
s = the y 
The value of 
to +1 or -1, 
r = (s /s )m X y 
standard deviation 
standard deviation 
r may vary from 0, 
of X 
of y. 
indicating no correlation, 
indicating perfect positive or negative correla-
tion. The significance of r was estimated from the expres-
sion: 
and a table of critical values of t was entered with (n-2) 
degrees of freedom for the two-tail test. 
5. THE LEVEL OF SIGNIFICANCE 
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Upon correctly entering a table of critical values of 
t a P value can be assigned to the difference between sample 
means, to the difference between the mean of the difference 
between pairs of observations and the hypothetical differ-
ence, and to the strength of a linear correlation which 
indicates the probability of an observed event occurring by 
chance. When P < 0.05, indicating that the observed event 
occurs less ·that 5% of the time by chance, the observation 
was considered to be significant. When P < 0.01, indicating 
that the observed event occurs less than 1% of the time by 
chance, the observation was considered to be very signifi-
cant. When P < 0.001, indicating that the observed event 
occurs less than 0.1% of the time by chance, the observa-
tion was considered to be highly significant. 
6. THE DISPLAY OF STATISTICAL DATA (Feinstein, 1976) 
In order to communicate data what is found should be 
shown by providing an indication of the central tendency of 
the data (the mean) and its dispersion (the standard devia-
tion). The standard error is not a summary of evidence 
hence it is not entirely proper to use it in summarizing 
data but its use is justified if the reported results are 
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immediately subjected to inferential testing (tests yielding 
p values). If no inferential tests are performed the only 
role of standard errors is to distort and conceal data. 
This is so because the data looks "tighter" if it is repre-
sented as the mean plus or minus the standard error rather 
than the mean plus or minus the standard deviation which, 
though larger than the standard error, is truely a summary 
of the dispersion of the data. 
If a graphical illustration of statistical signifi-
cance is desired a set of 95% confidence interval bars for 
the means, calculated using the pooled variance estimate for 
groups as calculated in testing the null hypothesis for 
the non-paired t-test, is preferred. If the 95% confidence 
intervals around two means do not overlap the difference 
between them is significant at P < 0.05. 
In the present dissertation data is communicated 
graphically as the mean plus or minus the standard error in 
order to describe the expected form of the curve not the 
dispersion of the data. Inferential testing. was performed 
on the raw data from which the graphs were constructed and 
the level of significance is indicated in the text where 
it is appropriate. If the reader wishes to know the disper-
sian of the data about the means in most cases it is only 
necessary to double the standard error in order to get the 
standard deviation since then is usually 4. However, 
statistically significant differences cannot necessarily be 
I 
'i 
inferred from the graphs since 95% confidence intervals 
are not indicated. 
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CHAPTER IV 
RESULTS 
CHAPTER IV 
RESULTS 
A. THE CORRELATION OF ERYTHROCYTIC ALAD ACTIVITY WITH BLOOD 
RETICULOCYTE PERCENT IN THE DEVELOPING MALE ALBINO RAT 
The variation of several hematologic indices and body 
weight with the age of the male albino rat is indicated in 
FIGURE 5. Both the hemoglobin (Hb) and the hematocrit (Ret) 
were observed to decrease in animals from 3 to 12 days of 
age. Following the initial drop, both of these values rose 
steadily from 12 days of age to 50 days of age when these 
indices were observed to plateau. On the other hand, both 
the mean corpuscular volume (MCV) and the mean corpuscular 
hemoglobin (MCH) decreased markedly in animals from 3 to 12 
days of age after which the values remained constant for the 
remainder of the age span studied. 
FIGURE 6 illustrates the variation of the blood retic-
ulocyte percent (Ret%) with the age of the male albino rat. 
As with the MCV and the HCH, a rapid decrease in the retic-
ulocyte percent was observed. The reticulocyte percent 
decreased from nearly 50% at age 5 days to 35% at 8 days of 
age and to approximately 25% at 12 days of age. This was 
followed by a slower decrease to approximately 10% at age 
35 days after which the reticulocyte percent appeared to 
plateau at just under 5%. 
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The mean peripheral blood values for the developing 
rat illustrated in these two figures are in excellent agree-
ment with the values reported in the literature (Lucarelli 
et al., 1964; Lucarelli et al., 1968). The unique picture 
of a macrocytic hypochromic anemia seen in the early neo-
natal period of the rat is observed to progress to a normo-
cytic, normochromic state shortly after the onset of puberty 
at 30 days of age and through the age of 93 days which was 
the limit of the present study. 
Erythrocytic ALAD activity was also found to decrease 
as a function of the age of the developing male albino rat 
(FIGURE 7). The ALAD activity of a 5 day old rat was near-
ly 55 mU/ml RBC. This decreased rapidly to 40 mU/ml P~C at 
8 days of age and to 30 mU/ml RBC at 12 days of age. The 
rapid decrease in erythrocytic ALAD activity during the 
early neonatal period was followed by a slower decrease to 
15 mU/ml RBC at 40 days of age and to approximately 5 mU/ml 
RBC thereafter up to 93 days of age. 
The similarity of the relationship between the retic-
ulocyte percent and the age of the male albino rat to the 
relationship between the erythrocytic ALAD activity and the 
age of the male albino rat suggested that there might be a 
linear relationship between erythrocytic A~AD activity and 
blood reticulocyte percent in the developing rat. FIGURE 8 
shows erythrocytic ALAD activity plotted as a function of 
the reticulocyte percent for each of the male albino rats 
studied. Linear relationship between erythrocytic ALAD 
activity and the reticulocyte percent was observed which 
can be described by the equation: 
y = 1. 2x + 3. 5 
where: 
y = the erythrocytic ALAD activity in mU/ml RBC 
x = the reticulocyte percent. 
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This linear relationship has a correlation coefficient of 
0.967 and a P value of less than 0.001; no significant 
correlation was observed for the relationship between eryth-
rocytic ALAD activity and any other measurement made in the 
present study. These data, therefore, indicate that the . 
proportional relationship that exists between erythrocytic 
ALAD activity and the number of reticulocytes in the periph-
eral blood of the developing male albino rat is highly 
significant. 
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B. THE GENDER-RELATED DIFFERENCES IN THE REFERENCE VALUES 
FOR THE NORMAL ADULT HUMAN ERYTHROCYTIC ALAD ACTIVITY 
The important reference values obtained for the sample 
population of normal, healthy, nonmedicated adult human male 
and female volunteers studied, including age, Hb, Ret, Ret%, 
and erythrocytic ALAD activity are presented in TABLE 1. 
Blood was obtained from 57 male volunteers having an average 
age of 36.3 years and from 49 female volunteers having an 
average age of 37.9 years; there was no statistically sig-
nificant difference between the mean ages of the male and 
the female volunteers. There was also no statistically sig-
nificant difference between the mean reticulocyte percents 
of the male and the female volunteers, the mean for both 
genders being 1.2%. There was, however, the expected 
(Harris and Kellermeyer, 1970) highly significant (P < 0.001) 
difference in the mean Hb and the mean Ret of the male and 
the female volunteers due to a difference in the level of 
androgenic hormone (McCullagh and Jones, 1942; Kennedy and 
Gilbertson, 1957) which enhances the production of erythro-
poietin as a result of a renotrophic effect (Mann et al., 
1968) and enhanced production of renal erythropoietic factor 
(Rencricca et al., 1969); the mean male Hb of 15.4 g/100 ml 
and Ret of 45.5% is approximately 10% greater than the mean 
female Hb of 13.6 g/100 ml and Ret of 40.9%. In contrast, 
the mean female erythrocytic ALAD activity of 48.2 mU/ml RBC 
was found to be very significantly (P < 0.01) greater than 
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the mean male erythrocytic ALAD activity of 44.2 mU/ml RBC. 
These values were normally distributed and there was no 
statistically significant correlation between erythrocytic 
ALAD activity and any other measurement made in the present 
study. 
C. THE ACTIVATION AND INHIBITION OF NORl1AL ADULT Hill'f..AN 
ERYTHROCYTIC ALAD BY 1:-1ETAL IONS IN VITRO 
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In light of the numerous contradictory reports con-
cerning the effect of metal ions on ALAD activity it became 
of interest to investigate the effects of various metal ions 
on normal adult human erythrocytic ALAD activity in vitro. 
As indicated above, these results were determined only on 
blood specimens obtained from normal, healthy, nonmedicated 
adult male and female volunteers with both a normal CBC and 
a normal erythrocytic ALAD activity. 
The first metal ion studied was Cu+2 (FIGURE 9), which 
was found to inhibit ALAD at very low concentrations. A 
very significant (P < 0.01) inhibition of ALAD to 72.5% of 
the control activity was observed at 9.3 x 10-7 M Cu+2 and 
higher concentrations of Cu+2 resulted in highly significant 
(P < 0.001) inhibition of ALAD. That concentration of Cu+2 
causing 50% inhibition of ALAD (In50) was determined to be 
2.5 x 10-6 M while that concentration of Cu+2 causing 90% 
inhibition of ALAD (In90 ) was determined to be 1.5 x 10-S M. 
It seemed quite natural to next determine the effect 
of Pb+2 on erythrocytic ALAD activity (FIGURE 10). Pb+2 
inhibits ALAD At very low concentrations, a highly signif-
icant (P < 0.001) inhibition of ALAD was observed at 9.3 x 
10-7 H Pb+2 and all higher concentrations. The rn50 for 
Pb+2 was found to be 1.9 x 10-6 M. While no Pb+2 concentra-
tion was found to inhibit ALAD more than 90%, the lowest 
Pb+2 In90 was determined to be 9.3 x 10-
6 M. 
The effect of zn+2 on human erythrocytic ALAD was 
determined next (FIGURE 10) and it was found to markedly 
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stimulate ALAD. Over a concentration range of 1.9 x 10 M 
-4 ', 
to 9.3 x 10 M, zn+2 was found to cause a highly signifi-
cant (P < 0.001) activation of erythrocytic ALAD. The con-
. f Z +2 . . . . f ALAD centrat~on o n caus~ng a max~mum act~vat~on o 
-4 (SD100) was 3.7 x 10 M and at that concentration the 
activity of ALAD was 157% of the control activity. At con-
centrations of 1.9 x 10-5 M and above zn+2 inhibited ALAD 
activity. 
Cadmium and mercury are, like lead and copper, heavy 
metals inhibiting enzymes with functional sulfhydryl groups 
but they are also, like zinc, members of Group IIB of the 
Periodic Table hence have physical and chemical properties 
similar to those of zinc. For this reason it was of inter-
est to discover the effects of Cd+2 and Hg+2 on ALAD activ-
ity (FIGURE 10) . 
H +2 g ' like Pb +
2 and c +2 u ' inhibits ALAD at very low 
concentrations. At a concentration of 4.0 x 10-6 M, Hg+2 
caused a very significant (P < 0.01) 9% decrease in ALAD 
activity. At concentrations of 10-5 M and above, Hg+2 
caused a highly significant (P < 0.001) decrease in erythro-
cytic ALAD activity. The ID50 for Hg+
2 was 6.0 x 10- 6 M. 
Low concentrations of Cd+2 , like zn+2 , activate eryth-
rocytic ALAD. At a concentration of 10-6 M Cd+2 caused a 
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significant (P < 0.05) increase in ALAD activity. Very 
significant (P < 0.01) increases in ALAD activity were ob-
served at the sn100 , 4.0 x 10-
6 M, and at 10-5 M Cd+2 , the 
maximum activity resulting from Cd+2 activation being 134% 
of the control activity. At higher concentrations Cd+2 
caused a highly significant (P < 0.001) inhibition of ALAD, 
the ID50 being 10-
4 M cd+2 . 
Having demonstrated not only the inhibition of erythro-
cytic ALAD by Pb+2 , Cu+2 , and Hg+2 but also its activation 
by Zn+2 and Cd+2 , the obvious question was whether or not 
an activator of ALAD could prevent or reverse the effect of 
an inhibitor. To that end the effects of zn+2 on an enzyme 
inhibited by ID50 Pb+
2 or In90 Pb+
2 (FIGURE 11) and on an 
enzyme inhibited by In50 Cu+
2 or In90 Cu+
2 (FIGURE 12) were 
determined and reactivation of the inhibited enzyme was 
observed. 
It was found that zn+2 is able to prevent or reverse 
the ID5o Pb +2- and ID5o Cu+
2
-induced inhibition of erythro-
cytic ALAD (FIGURE 13). While In50 Pb+
2 caused a highly 
significant (P < 0.001) decrease in ALAD activity, all con-
centrations of Zn +Z from 1. 9 x 10-5 M to 1. 9 x 10-3 M 
caused a highly significant (P < 0.001) increase in the 
activity of the inhibited enzyme. Indeed, at concentrations 
of 1.9 x 10-4 M zn+2 and above there was no difference from 
the activity of the zn+2 activated control. In a similar 
manner, In50 Cu+
2 caused a highly significant (P < 0.001) 
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decrease in ALAD activity which was prevented or reversed 
by Zn+2 at concentrations from 9.3 x 10-5 M to 9.3 x 10- 3 M. 
While zn+2 caused a highly significant (P < 0.001) increase 
in the activity of ALAD with respect to the activity of the 
+2 ID50 Cu control, the reactivation of ALAD was not as 
complete as that observed for Pb+2-induced inhibition. In 
fact, the maximum activity observed when zn+2 was added to 
h ID C +2 . h"b" d 106~ f h 1 t e 50 u Ln L Lte enzyme was ~ o t e centro 
activity at 3.7 X 10-4 M zn+2 . 
The highly significant (P < 0.001) inhibition of 
+2 erythrocytic ALAD by In90 Pb was also prevented or re-
versed by 1.9 x 10-5 M to 1.9 x 10-3 M zn+2 (FIGURE 14). 
~~ile at zn+2 concentrations below 9.3 x 10-4 M there was a 
significant decrease from the activities observed in the 
presence of those concentrations of zn+2 alone, the in-
creases in activity were still highly significant (P < 0.001). 
Indeed, at 1.9 x 10-4 M and 3.7 x 10-4 11 zn+2 the ALAD 
activities were 107% and 134% of the uninhibited control 
activities, respectively, despite the presence of In90 Pb+
2 
zn+2 was unable to similarly prevent or reverse the highly 
significant (P < 0.001) ID90 Cu+
2
-induced inhibition. Only 
+2 . f -4 -3 at Zn concentratLons o 3.7 x 10 M to 1.9 x 10 M were 
very significant (P < 0.01) increases in ALAD activity ob-
served and then the maximum activity observed was only 25% 
of the uninhibited control ALAD activity at 1.9 x 10-3 M. 
These results raised the question of which physical 
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and chemical properties are associated with the ability of 
a metal ion to activate or inhibit human erythrocytic ALAD. 
A natural corollary of this question is whether or not these 
properties are unique to a single metal ion. In order to 
answer this question various metal ions having physical and 
chemical properties similar to those of zn+2 or Pb+2 or 
those previously reported to activate or inhibit ALAD were 
selected and their effects on both normal human erythrocytic 
ALAD and on normal erythrocytic ALAD inhibited by ID50 Pb+
2 
were determined. In addition, the ability of sn100 Zn+
2 to 
prevent or reverse the effects of these various ions was 
determined. In all cases the control inhibition of erythro-
cytic ALAD by ID50 Pb+
2 and the control activation of the 
+2 enzyme by sn100 Zn were at least very significantly 
(P < 0.01) different from the uninhibited and unactivated 
control erythrocytic ALAD activity. 
FIGURE 15 illustrates the results obtained for Pb+2 , 
In this figure it will be noted that, 
while the borderline Lewis acid Pb+2 at concentrations of 
9.3 x 10-7 M and above cause a highly significant (P < 0.001) 
-4 inhibition of adult human erythrocytic ALAD, 3.7 x 10 M 
+2 Zn completely prevented or reversed this inhibition even 
at very high concentrations of Pb+2 where a slight, albeit 
insignificant, decrease in the activity of the zn+2 acti-
vated enzyme was observed. The soft Lewis acid Hg+2 sim-
ilarly caused a highly significant inhibition of ALAD at 
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concentrations of 4.0 x 10-6 M and greater but this inhibi-
+2 tion could not be prevented or reversed by sn100 Zn and 
Hg+2 did not prevent or reverse the inhibition of ALAD by 
ID50 Pb+
2
. Instead, the inhibition caused by Hg+2 at 
concentrations above 10-5 M was additive with both the 
stimulation by zn+2 and the inhibition by Pb+2 in a highly 
significant (P < 0.001) and a very significant (P < 0.01) 
manner, respectively. As has already been discussed, the 
+2 borderline Lewis acid Zn not only caused a highly signifi-
cant (P < 0.001) activation of ALAD at concentrations from 
1.9 x 10-S M to 9.3 x 10-4 M but also completely prevented 
+2 
or reversed the effects of In50 Pb ove.r a concentration 
range of 1.9 x 10-S M to 1.9 x 10- 3 M. The soft Lewis acid 
Cd+2 caused a significant (P < 0.05) to highly significant 
(P < 0.01) increase in ALAD activity over the concentration 
range of 10- 6 M to 10-S M. Cd+2 from 10-S M to 4.0 x 10-4 M 
1 d d h ID Pb+2 . d d . h. b. . a so prevente or reverse t e 50 -~n uce ~n ~ ~t~on 
of ALAD, causing a very significant (P < 0.01) increase in 
ALAD activity to as high as 111% of the uninhibited control 
. . 10-S 1..1 act~v~ty at ~. -5 At concentrations of 4.0 x 10 M and 
above Cd+2 caused a highly significant (P < 0.001) inhibi-
tion of ALAD that could not be prevented or reversed by 
SDlOO zn+2. 
In FIGURE 16 the effects of the hard Lewis acids Na+, 
Mg+2 , Al+3 , and Mn+2 on normal, In50 Pb+
2 inhibited, and 
sn100 Zn+
2 stimulated ALAD are illustrated. It will be 
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noted that over a concentration range of 1.9 x 10-6 M to 
1.9 x 10-3 M Na+ had no effect on the normal, Pb+2 inhibited, 
or zn+2 activated enzyme. Similarly, Mg+2 and Mn+2 had no 
effect on the normal, Pb+2 inhibited, or Zn+2 activated 
enzyme at concentrations from 10- 7 M to 10-3 M. Except at 
concentrations above 4.0 x lo-3 M Al+3 had no effect on 
normal, Pb+2 inhibited, or zn+2 activated ALAD. At 10-2 M 
Al+3 caused a highly significant (P < 0.001) decrease in 
ALAD activity to 49% of the control activity hence this was 
considered to be the Al+3 rn50 . This inhibition by Al+
3 
+2 could not be prevented or reversed by sn100 Zn , rather 
4.0 x 10-3 M and 10-2 M Ai+3 caused a highly significant 
(P < 0.001) decrease in the activity of the zn+2 activated 
enzyme. Similarly, the Al+3-induced inhibition of ALAD 
+2 was additive with that produced by rn50 Pb and no 
concentration of Al+3 prevented or reversed the rn50 Pb+
2
-
induced inhibition of ALAD. 
Monovalent silver is a soft Lewis acid with the same 
10 . +2 +2 d valence electronic configuration found ~n Zn , Cd , 
and Hg+2 However, Ag+ (FIGURE 17), unlike zn+2 and Cd+2 
but like Hg+2 , was only found to inhibit ALAD in the concen-
tration range studied. At concentrations of 2.0 x 10-6 M 
and greater Ag+ caused a highly significant (P < 0.001) 
decrease in ALAD activity, the rn50 being 2.0 x 10-
6 M. Ag+ 
+2 did not prevent or reverse the inhibition of rn50 Pb nor 
could the Ag+-induced inhibition by prevented or reversed by 
li 
II 
II 
:I 
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sn100 zn+Z Rather, the Ag+-induced inhibition was additive 
with the activation by zn+Z and the inhibition by Pb+Z in a 
highly significant (P < 0.001) manner. 
Trivalent gallium and indium also have d10 valence 
electronic configurations but, unlike the other d10 ions 
already discussed which are soft or borderline Lewis acids, 
Ga+3 and In+3 are hard Lewis acids. Both Ga+3 and In+3 
(FIGURE 18) caused a very significant (P < 0.01) inhibition 
of adult human erythrocytic ALAD activity at concentrations 
of 4.0 x 10-4 M and 10-3 M, the In50 for both being 7.0 x 
10-4 M. The inhibition produced by both Ga+3 and In+3 could 
+2 be prevented or reversed by sn100 Zn throughout the con-
centration range studied. Ga+3 and In+3 were, however, un-
able to prevent or reverse the inhibition of ALAD by ID50 
Pb+2 , the inhibition by both Ga+3 and In+3 actually caused 
a very significant (P < 0.01) increase in the Pb+2-induced 
inhibition of erythrocytic ALAD. 
The effects of the last metal ions studied, Sn+Z and 
S +4 n ' are illustrated in FIGURE 19. The borderline Lewis 
acid Sn+Z has the s 2d10 valence electronic configuration of 
Pb+Z and, like Pb+2 , caused an inhibition of erythrocytic 
ALAD at very low concentrations that could be prevented or 
reversed by zn+2 . At concentrations of 10-5 M and above 
Sn+Z caused a highly significant (P < 0.001) inhibition of 
ALAD, the ID50 for Sn+Z being 4.0 x 10-
5 M. The Sn+Z_ 
induced inhibition of ALAD could be completely prevented or 
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+2 -3 +2 
reversed by sn100 Zn up to 10 I1 Sn where a very 
significant (P < 0.01) decrease in the activity of the zn+2 
activated enzyme was observed. Sn+2 could not prevent or 
reverse the rn50 Pb+
2
-induced inhibition but the inhibition 
produced by Sn+2 at concentrations of 4.0 x 10-S M and 
greater was additive with that produced by rn50 Pb+
2 The 
hard Lewis acid Sn+4 has the same valence electronic config-
uration as Ag+, zn+2 , Cd+2 , Hg+2 , Ga+3 and In+3 . Sn+4 
caused a very significant (P < 0.01) inhibition of ALAD only 
at a concentration of 4.0 x 10-4 M and above and this inhibi-
tion was additive with the sn100 zn+
2 stimulation. At a con-
centration of 10-4 M Sn+4 was able to cause a highly signifi-
cant (P < 0.001) reversal of the rn50 Pb+
2
-induced inhibi-
tion but only to 67% of the uninhibited control ALAD 
activity. At 10-3 M the inhibition produced by Sn+2 caused 
a very significant (P < 0.01) increase in the inhibition 
+2 caused by rn50 Pb . 
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D. THE EFFECT OF PREINCUBATION ON THE ACTIVATION AND INHI-
BITION OF NORMAL ADULT HUMAN ERYTHROCYTIC ALAD BY METAL 
IONS IN VITRO 
In order to further investigate the interesting 
effects of Pb+2 , Zn+2 , Cd+2 , ~nd Hg+2 on normal human eryth-
rocytic ALAD, various concentrations of these cations were 
added to hemolysates which were then incubated at 37°C for 
1.0 hour before adding the substrate. These results are 
compared with the effect of these metal ions on normal adult 
human erythrocytic ALAD activity when they were added to 
hemolysates immediately prior to adding the substrate. The 
activity of control hemolysates incubated for 1.0 hour at 
37°C before adding the substrate was not significantly 
different than the activity of a nonpreincubated control 
hemolysate. 
FIGURE 20 illustrates the effect of various concentra-
tions of Pb+2 and Hg+2 on normal adult human erythrocytic 
ALAD when added without preincubation and before a 1.0 hour 
preincubation of the hemolysate. As indicated in this 
figure, a 1.0 hour preincubation enhanced the inhibition of 
erythrocytic ALAD by Pb+2 , causing a very significant (P < 
0.01) decrease in the In50 from 1.9 x 10-
6 M Pb+2 without 
preincubation to 6.2 x 10- 7 M with a 1.0 hour preincubation. 
A 1.0 hour preincubation of the whole blood hemolysate with 
Hg+2 similarly enhanced the ability of Hg+2 to inhibit ALAD, 
causing a very significant (P < 0.01) decrease in the In50 
113 
+2 6 for Hg from 6.0 x 10- M without preincubation to 1.9 x 
10-6 M with a 1.0 hour preincubation. 
FIGURE 21 illustrates the effects of a 1.0 hour prein-
cubation with the metal ion on the activation of erythro-
cytic ALAD by zn+2 and on the activation and inhibition by 
Cd+2 . A 1.0 hour preincubation with the hemolysate had no 
significant effect whatsoever on the ability of Zn+2 to 
activate erythrocytic ALAD. On the other hand, a 1.0 hour 
preincubation of the enzyme with Cd+2 not only caused a 
very significant (P < 0. 01) enhancement of the Cd+2·-induced 
inhibition of ALAD, changing the rn50 from a non-preincuba-
tion concentration of 8.0 x 10-5 M to 2.5 x 10-6 M with a 
1.0 hour preincubation, but it also completely prevented the 
Cd+2 activation of erythrocytic ALAD. The Cd+2 sn100 caused 
a very significant (P < 0.01) activation of erythrocytic 
ALAD to 124% of the control activity when added without 
preincubation but caused a highly significant (P < 0.001) 
decrease to 42% of the control activity when preincubated 
with the enzyme for 1.0 hour. 
Additional experiments were conducted in which various 
concentrations of Pb+2 , Cd+2 , or Zn+2 were added to the hemo-
lysates without preincubation or prior to preincubation for 
0.5, 1.0, 2.0, and 4.0 hours at 37°C before adding the sub-
strate. The activities of control hemolysates preincubated 
for 0. 5 or 1. 0 hour prior to adding the substrate -.;.Jere not 
significantly less than the activity of a nonpreincubated 
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control hemolysate but the activities of control hemolysates 
preincubated for 2.0 or 4.0 hours were. 
The enhancement of Pb+2-induced inhibition previously 
described for a 1.0 hour preincubation with Pb+2 is already 
apparent after a 0.5 hour preincubation with Pb+2 and 
becomes more marked with 2.0 and 4.0 hours of preincubation 
(FIGURE 22). That this is not due solely to denaturation of 
the enzyme on preincubation is suggested by FIGURE 23 in 
which the results of the preceeding figure are plotted as a 
function of the preincubation time. While the control 
activity decreases after 2.0 and 4.0 hours of preincubation, 
the inhibition induced by various concentrations of Pb+2 
increases at a faster rate beginning at earlier preincuba-
tion times. 
In a similar manner, the prevention of the activation 
of ALAD by Cd+2 and the enhancement of Cd+2-induced inhibi-
tion as a result of a 1.0 hour preincubation of the hemoly-
sate with Cd+2 is notable after 0.5 hour of preincubation 
with the· enzyme and is more marked after 2.0 and 4.0 hours 
of preincubation (FIGURE 24). Again, when these results 
are represented as a function of the preincubation time 
(FIGURE 25), it can be seen that this is apparently a true 
preincubation phenomenon and not solely due to denaturation 
of the enzyme as a result of the preincubation. 
As can be seen in FIGURES 26 and 27, preincubation of 
the hemolysate with zn+2 for 0.5, 1.0, 2.0, and 4.0 hours 
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had little effect on the zn+2 activation of human erythro-
cytic ALAD. This is in marked contrast to the effects of 
preincubation on the effects of Pb+Z and Cd+Z on ALAD. 
Further experiments were conducted to determine 
whether the enhancement of Pb+2-, Hg+Z and Cd+2 -i~duced 
inhibition and the prevention Cd+Z activation of ALAD 
after preincubation with these cations is the result of 
denaturation of the enzyme during preincubation, rendering 
it more susceptible to inhibition, or a true preincubation 
phenomenon. In these experiments the effect of various con-
centrations of Pb+2 , zn+2 , Cd+2 , and Hg+Z on ALAD activity 
was determined when these ions were added without preincuba-
tion, before a 1.0 hour preincubation, and after a 1.0 hour 
preincubation (FIGURE 28). It was found that there is 
little, if any, difference between the results obtained when 
the metal ions were added without a 1.0 hour preincubation 
or after a 1.0 hour preincubation. Similarly, the results 
obtained when metal ions were added after a 1.0 hour prein-
cubation were as significantly different from those obtained 
when the metal ions were added prior to a 1.0 hour preincu-
bation as the results obtained when the metal ions were 
added without preincubation were. It, therefore, seems 
apparent that the enhancement of the Pb+2-, Hg+2-, and Cd+Z_ 
induced inhibition and, especially, the elimination of the 
Cd+Z activation may indeed be the result of a true preincu-
bation phenomenon and not of protein denaturation. 
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The final consideration of the present research was to 
determine whether or not preincubation would interfere with 
the ability of Zn+2 to affect the reactivation of Pb+2 
inhibited ALAD. The ID50 of Pb+
2 determined under nonprein-
cubation conditions was added to the hemolysates after 
preincubation for 1.0 hour with various concentrations of 
+2 I dd. . . . f Z +2 Zn . n a ~t~on, var~ous concentrat~ons o n were 
added to hemolysates after preincubation for 1.0 hour with 
the preincubation ID50 Pb+
2 Finally, the preincubation 
In50 Pb+
2 and various concentrations of zn+2 were added to 
the hemolysate prior to preincubation for 1.0 hour. 
As can be seen in FIGURE 29, zn+2 is able to complete-
ly prevent or reverse the effect of a preincubation rn50 
Pb+2 whether zn+2 was added after a 1.0 hour preincubation 
with Pb+2 or was preincubated simultaneously with Pb+2 . A 
~ -4 ~ Zn concentration of 3.7 x 10 M reversed the Pb -induced 
inhibition of ALAD to 132% of the uninhibited, nonpreincubat-
ed control activity when added after preincubation with 
Pb+2 and to 137% of the control activity when preincubated 
simultaneously with Pb+2 . 
It will be noted in FIGURE 30 that preincubation with 
zn+2 was able to completely prevent the inhibitory effects 
of Pb+2 on ALAD whether the inhibition was caused by preincu-
bation ID50 Pb+
2 or by nonpreincubation In50 Pb+
2 A concen-
tration of 3.7 x 10-4 M zn+2 reversed the Pb+2-induced inhi-
bition of ALAD to 140% of the uninhibited, nonpreincubated 
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+2 
control activity when Pb was added after preincubation 
+2 
with Zn and to 137% of the control activity when preincu-
bated simultaneously with Pb+2 . 
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A. THE IMPLICATIONS OF THE ASSOCIATION OF THE DECREASE IN 
ERYTHROCYTIC ALAD ACTIVITY WITH THE DECREASE IN RETICU-
LOCYTE PERCENT IN THE DEVELOPING }MLE ALBINO RAT 
Because a decrease in erthrocytic ALAD activity is 
often used as an index of the degree of lead intoxication, 
the correlation of a decrease in the activity of erythrocy-
tic ALAD with a decrease in the reticulocyte percent as the 
normal male albino rat develops could be an important source 
of variability in the analysis of the lead intoxication of 
newborn and developing rats. This should, therefore, be 
carefully controlled for or the erythrocytic ALAD assay 
should be completely avoided when evaluating the degree of 
experimental lead intoxication of newborn and developing 
male (and, presumably, female) albino rats. 
The prolonged elevation of erythrocytic ALAD activity 
and reticulocyte percent observed in the developing rat may 
well reflect a prolonged net peripheral heme biosynthesis; 
whether or not it actually does remains to be investigated. 
In light of this possibility, a consideration of the age of 
the animal might also be in order when using the newborn 
and developing male albino rat as a model for other dis-
orders of heme synthesis including the porphyrias. 
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The association of a decrease in erythrocytic ALAD 
activity with a decrease in the reticulocyte percent as the 
male albino rat develops suggests that with the maturation 
of the erythrocyte there is a gradual decline in the activ-
ity of the soluble cytoplasmic enzyme ALAD in addition to 
the expected loss of the mitochondrial heme biosynthetic 
enzymes. While the association of a high ALAD activity with 
a large population of young cells capable of synthesizing 
protein suggests the loss of ALAD activity as the nonnu-
cleated cell population ages is due to protein degradation 
or to protein denaturation (due to such factors as oxidation 
of -SH groups to -s-s- bonds or to dissociation of the 
enzyme subunits) it certainly does not prove it. The de-
cline in erythrocytic ALAD activity with a decrease in the 
reticulocyte percent and an increase in the age of the ani-
mal may reflect an increased body burden of the ubiquitous 
environmental contaminant and ALAD inhibitor Pb+Z as the 
animal ages. The decrease in the ALAD activity with a de-
crease in the reticulocyte percent and increase in the.age 
of the animal may also reflect a difference in the content 
or metabolism of a cofactor of ALAD (such as zn+2-see below) 
in the young versus the old cells or to a difference in the 
serum levels or whole animal metabolism of such a cofactor 
at various stages of development. Such possibilities could 
be explored in this animal model and could possibly provide 
some insights into one of the basic processes of ageing-the 
121 
alteration of enzymes (Rothstein, 1975). This model could 
be especially useful for the study of the alteration of 
enzymes on ageing since the role of sequence changes during 
protein synthesis in this process could be more easily con-
trolled for than in other model systems in which the cells 
are nucleated. 
Abdulla et al. (1978a) have recently confirmed the 
observation of a very high erythrocytic ALAD activity in 
rats after partus and of a marked decrease in the activity 
of the enzyme during the early growth period of the rat. 
While these investigators could not measure plasma and 
whole blood zn+Z concentrations in young animals, they did 
find that animals less than six weeks old when fed a zinc 
deficient diet had a significantly lower ALAD activity than 
those animals fed a diet containing adequate levels of zinc. 
In older animals, on the other hand, the level of dietary 
zinc had no effect on erythrocytic ALAD activity. In 
addition, since hepatic zinc plays an active role in zinc 
homeostasis (Abdulla et al., 1978b) and hemoglobin synthe-
sis during fetal and early developmental growth in the rat 
occurs in the liver, these investigators examined the zinc 
status of the liver and found that the livers of newborn 
rats had zinc levels three times higher than those of adult 
rats. This, together with the finding that in zinc defi-
ciency the hepatic zinc levels were also decreased, may 
offer some explanation of the differences in ALAD activity 
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as the animal develops. More work certainly remains to be 
done to further investigate this. 
In the same article Abdulla and associates also re-
ported the observation that the erythrocytic ALAD activity 
of human infants is nearly one and one-half times that of 
the adult human. Plasma zn+2 concentrations of the newborn 
are 25% higher than those of the adult while whole blood 
Zn+2 levels are 50% lower than those of the adult. This is 
consistent with the earlier observation (Haeger-Aronsen et 
al., 1976) that erythrocytic ALAD activity could be strongly 
+2 
correlated with plasma Zn levels and more weakly correla-
ted with erythrocyte zn+2 levels. However, this also raises 
an interesting question needing further clarification be-
cause the plasma zn+2 levels reported by these investigators 
for adult rats is significantly higher than that reported 
for the adult human yet the adult rat has a much lower 
erythrocytic ALAD activity than has the adult human. 
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B. THE POSSIBILE EXPLANATIONS FOR THE GENDER-RELATED DIFFER-
ENCE IN NORMAL ADULT HUMAN ERYTHROCYTIC ALAD ACTIVITY 
The biological significance of the gender-related dif-
ference in normal adult human erythrocytic ALAD activity is 
minimal on the basis of the present information since it has 
been suggested that there is excess enzyme in the body 
(Lauwerys et al., 1974) and, more importantly, because the 
mature erythrocyte does not synthesize heme. However, this 
sex-related difference could reflect higher absolute levels 
of the enzyme in the erythroid precursors and the other 
cells of the body, possibly as a reflection of a higher rate 
of porphyrin synthesis in the female. The gender-related 
difference in erythrocytic ALAD activity could also be a 
reflection of higher plasma or whole blood concentrations 
or differences in the metabolism of a cofactor of ALAD (such 
as zn+2 or Cu+-see below) or a lower concentration of an 
inhibitor of ALAD (such as Pb+2). 
The possibility that the sex-related difference in 
erythrocytic ALAD activity is due to a sex-related differ-
ence in the blood lead level is unlikely since it has been 
found, after an exhaustive international study, that the 
blood level of normal adult males is not significantly 
different than that of the normal adult females (Goldwater 
and Hoover, 1967). Similarly, the possibility that this 
difference is due to a sex-related difference in the levels 
of zinc, a possible activator of ALAD, is unlikely since it 
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has been reported that there are no gender-related differ-
ences in whole blood, erythrocytic, or plasma zinc levels 
(Vallee and Gibson, 1948; Halsted and Smith, 1970). A 
possible explanation of the sex-related difference in eryth-
rocytic ALAD activity that merits further consideration is 
the fact that female serum copper levels are significantly 
higher than male serum copper levels (Lahey et al., 1953; 
Bloomfield and MacMahon, 1969); this relationship is particu-
larly interesting in light of the possibility, discussed 
below, that Cu+ is the true in vivo activator of ALAD. 
Until further research explains the reason for the 
difference between the mean male and female erythrocytic 
ALAD activities, this sex-related difference should be con-
sidered when establishing reference values for the erythro-
cytic ALAD assay used as a diagnostic aid in the evaluation 
of lead intoxication. 
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C. THE CONSIDERATIONS REGARDING THE EFFECT OF HETAL IONS ON 
NORMAL ADULT HUMAN ERYTHROCYTIC ALAD ACTIVITY IN VITRO 
1. THE GENERAL CONCLUSIONS CONCERNING THE PHYSICAL AND CHEH-
ICAL PROPERTIES ASSOCIATED WITH THE ABILITY OF HETAL IONS 
TO ACTIVATE OR INHIBIT HID1AN ERYTHROCYTIC ALAD IN VITRO 
The findings of the present study that low concentra-
+2 + +2 +2 +2 tions of Cu , Ag , Hg , Sn , and Pb inhibit normal 
adult human erythrocytic ALAD in vitro at very low concentra-
tions is entirely consistent with the reports of others 
(Calissano et al., 1965; Tomio et al., 1968; Chiba and 
Kikuchi, 1978) and is not surprising in light of the sulfhy-
d 1 f ALAD Z +2 . . f h h . ry nature o . n actLvatLon o uman eryt rocytLc 
ALAD is also consistent with the reports of others of the 
Zn+2 activation of ALAD from human and other mammalian 
sources (Abdulla and Haeger-Aronsen, 1971; Cheh and Neilands, 
1973; Finelli et al., 1974) as is the prevention or reversal 
of Pb+2-induced inhibition of ALAD by zn+2 (Finelli et al., 
1975). Ind~ed, recent reports have confirmed the observa-
tion of zn+2 activation of ALAD (Mitchell et al., 1977) as 
well as the protective effect of zn+2 against Pb+2-induced 
inhibition of ALAD (Border et al., 1976b, Haeger-Aronsen, et 
al. , 1976; Cantrell et al. , 1977). 
Normal human whole blood concentrations of zinc are 
1.35 + 0.31 x 10-4 M (Vallee and Gibson, 1948) which 
corresponds favorably with the in vitro concentrations of 
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zinc used in the present study. Normal whole blood concen-
trations of lead are 0.7-1.9 x 10-6 M (Goldwater and Hoover, 
1967) which are also within the range of the in vitro con-
centrations of lead used in the present study; indeed, lead 
has been reported to inhibit human erythrocytic ALAD in vivo 
at whole blood concentrations much lower than the supposedly 
safe upper limit of normal (Hernberg et al., 1970). In 
addition, evidence of clinical lead toxicity can be observed 
at whole blood lead concentrations above 2.8 x 10-6 M 
(Gibson et al., 1968). 
The suggestion that the in vitro addition of Cd+2 can 
stimulate ALAD activity (Wilson et al., 1972; Cheh and 
Neilands, 1973; Ramp and Kriebitzsch, 1975) was unequivocal-
ly demonstrated in the present study and was later confirmed 
(Mitchell et al., 1977). That Cd+2 is able to prevent or 
reverse Pb+2-induced inhibition of ALAD is a unique finding 
of the present investigation. Preincubation studies in the 
present work, however, give reason to doubt the possibility 
that activation of ALAD by Cd+2 might be observed in vivo 
since prolonged exposure of the enzyme to Cd+2 causes enzyme 
inhibition. 
While the activation of ALAD by 0.18 mM zn+2 reported 
by Meredith and associates (1974) was exactly duplicated in 
this study their often cited observation of Al+J activation 
of ALAD was not. This discrepancy might be explained by 
their use of a potassium phosphate buffer in their assay and 
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is not unexpected in light of the hard Lewis acid character 
+3 of Al and the presence of many soft Lewis base sites, the 
sulfhydryl groups, on the enzyme. 
The reported activation of human erythrocytic ALAD by 
Mn+2 (Collier, 1971) could not be reproduced in the present 
investigation. That the hard Lewis acid lm+2 has no effect 
on ALAD except at very high concentrations was recently 
confirmed (Hitchell et al., 1977). 
The report by Hitchell et al. (1977) of the activation 
of ALAD by 10-S H Hg+2 is inconsistent with the already 
mentioned reports of others of inhibition of ALAD by Hg+2 
at these concentrations and could not be reproduced in the 
present study. TI!e findings of Mitchell and co-workers is 
contrary to what is expected on the basis of the properties 
of Hg+2 for, while 
f . . Cd+2 ~gurat~on as 
+2 Hg has the same valence electronic con-
d Z +2 . . . h an n , ~n v~tro act~vators or eryt ro-
cytic ALAD, its chemical properties are quite different than 
other members of Group IIB of the Periodic Table, as 
discussed below. 
The metal ions Na+, Hg+2 G +3 I +3 a , n , +4 and Sn were 
not found to have any significant effect on human erythro-
cytic ALAD activity except at very high concentrations and 
there is no report in the present literature of any signifi-
cant effect of these metal ions on the ALAD from any other 
mammalian source. 
TABLE 2 lists the physical and chemical properties of 
f 
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metal ions generally considered of importance in the inter-
action of metal ions with proteins for each of the 14 metal 
ions investigated in the present study. These properties 
include oxidation state, valence electronic configuration, 
characteristic coordination number, coordination geometry, 
and Pearson HSAB classification of Lewis acids. In addition, 
T~~LE 2 summarizes the effects of these metal ions on eryth-
rocytic ALAD by listing the ID50 and the sn100 . Several 
important conclusions concerning the physical and chemical 
properties associated with the ability of a metal ion to 
activate or inhibit erythrocytic ALAD in vitro can be 
reached on the basis of the above results. 
On the basis of the present study it can be concluded 
that hard acids have no effect on erythrocytic ALAD in vitro 
except at concentrations approaching the millimolar range, 
very high concentration for a metal-protein interaction. 
Thus even those hard acids with the same valence electronic 
f . . Z +2 d Cd+2 (" G +3 I +3 and Sn+4) con ~gurat~ons as n an ~.e. a , n , 
or with the same oxidation state as Zn+2 and Cd+2 (i.e. Mg+2 
and 1~+2 ) were found to be without effect on erythrocytic 
ALAD except at very high concentrations. This implies that 
activation and inhibition of ALAD is due to the interaction 
of the metal ions with a soft Lewis base of the enzyme, such 
as the sulfhydryl group, rather than with a hard Lewis base. 
The present evidence indicates that borderline or 
soft Lewis acids having a planar coordination geometry and 
II• 
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either a characteristic coordination number that does not 
give the ion the electronic configuration of a noble gas, 
hence have empty £ orbitals into which electrons can be 
donated by a ligand in a ~ bond, or a characteristic coor-
dination number that gives the ion the electronic configura-
tion of a noble gas and a geometry that permits donation of 
~ electrons to a ligand in a ~ bond which reduces the 
negative charge on the central ion, inhibit ALAD at very 
low concentrations. Thus, despite having the same valence 
~ ~ . 
electronic configuration as Zn and Cd , the soft Lew~s 
'd A+ d H +2 . h h . . d' . ac~ s g an g , w~t a c aracter~st~c coer ~nat~on 
number of 2 (which will not give them the electronic con-
figuration of a noble gas that a coordination number of 4 
would) and a linear coordination geometry, inhibit erythro-
cytic ALAD. Similarly, the borderline Lewis acids Sn+2 and 
Pb+2 , despite having the same oxidation state as zn+2 and 
Cd+2 , have a planar coordination geometry (~-tetrahedral) 
which permits the donation of ~ electrons to ligands in a ~ 
coordinate bond and inhibit the enzyme. These Lewis acids 
could, therefore, form not only a a coordinate-covalent 
bond with a soft Lewis base of the enzyme, such as the 
sulfhydryl group, but also a much more stable bond by ~ bond 
formation through either accepting electrons from sulfur 
into empty£ orbitals (i.e. Ag+ and Hg+2) or donating 
'+2 electrons into an empty ~orbital of sulfur (i.e. Sn and 
+2 Pb ), thereby inhibiting the enzyme. 
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Of the 14 metal ions studied, only the borderline 
Lewis acid zn+2 and the soft Lewis acid Cd+2 activate eryth-
rocytic ALAD in vitro and prevent or reverse the in vitro 
Pb+2-induced inhibition of erythrocytic ALAD. These are 
d . 1 dlO L . "d . h h . . d" . ~va ent, ew~s ac~ s w~t a c aracter~st~c coor ~nat~on 
number of 4 that gives them the electronic configuration of 
a noble gas and a nonplanar coordination geometry (tetrahe-
dral). Thus both zn+2 and Cd+2 are able to readily form 
only a cr coordinate covalent bond with a soft Lewis base of 
the enzyme, such as the sulfhydryl group. 
Because all of the metal ions affecting the activity 
of normal adult human erythrocytic ALAD are borderline or 
soft Lewis acids it seems reasonable to assume that they are 
all acting at the same soft Lewis base site of the enzyme 
with activation or inhibition of the enzyme depending on 
the relative strengths of the coordination bond formed. The 
fact that the -SH group, a soft Lewis base, is the most 
active group found in cells, with coordinate covalent bond-
ing leading to metal mercaptide formation being among the 
most specific of its reactions (Boyer, 1959), together with 
the fact that ALAD contains a very large number of -SH 
groups (Wilson et al., 1972; Shemin, 1972; Tsukamoto et al., 
1975; Shemin, 1976) strongly suggests that the soft Lewis 
base with which these metal ions interact is the -SH group. 
In addition, the sulfur atom of the -SH group has both empty 
~ orbitals that can accept electron pairs from a central ion 
131 
and unshared pairs of electrons that can be donated to a 
central ion in the formation of rr coordinate bonds which 
would, in either case, be strong enough to account for inhi-
bition of the enzyme by metal ions. 
Both zn+2 and Cd+2 are able to prevent or reverse the 
in vitro inhibition of ALAD induced by the borderline Lewis 
acid Pb+2 . zn+2 is also able to prevent or reverse the in 
vitro inhibition of ALAD induced by the borderline Lewis 
acid Sn+2 but not that induced by the soft Lewis acids Ag+ 
and Hg+2 These results are easily explained if all six 
ions compete for the same binding sites on the enzyme. The 
+2 +2 borderline acid-soft base bond formed by Pb an4 Sn with 
the enzyme appears to be strong enough to inhibit the enzyme 
but weak enough (perhaps due to TI bond formation by donation 
of the electron pairs of the metal ions to the empty d 
orbitals of the sulfide) to permit exchange with sufficient-
ly high concentrations of zn+2 or Cd+2 . The soft acid-soft 
base bond formed by Ag+ and Hg+2 with the enzyme appears to 
be strong enough to not only inhibit the enzyme but also 
(perhaps due to TI bond formation by donation of the electron 
pair of sulfur to the empty £ orbitals of the metal ions) to 
prevent exchange with zn+2 no matter how high the concentra-
tion. Thus Pb+2 and Sn+2 may exchange readily with Zn+2 and 
Cd+2 but Ag+ and H +2 t h "th Z +2 b g may no exc ange wL n ecause TI 
bonds that do not contribute to completing a noble gas elec-
tronic configuration are more readily broken than those that 
I'' I 
I 
I 
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do. 
The unique ability of zn+2 to both activate ALAD in 
. d h . . Pb+ 2 . d d v1tro an to prevent or reverse t e 1n v1tro -1n uce 
inhibition of ALAD even after a 1.0 hour preincubation with 
the enzyme emphasizes the importance of not only the diva-
lent, d10 characteristics with a characteristic coordination 
number that gives the metal ion a noble gas electronic con-
figuration and a nonplanar coordination geometry but also 
the borderline Lewis acid characteristics of a metal ion 
activator of ALAD. The failure of Cd+2 to activate ALAD 
in vitro after even a 0.5 hour preincubation with the enzyme 
11 h . b. 1' f z +2 h as we as t e 1na 1 1ty o n to prevent or reverse t e 
Cd+2-induced inhibition of ALAD is most likely related to 
the soft Lewis acid characteristics of Cd+2 since its other 
important properties are the same as those of zn+2 . It is 
possible that on preincubation the kinetics of the Cd+2-
enzyme interaction permit Cd+2 to assume a 6 coordinate 
octahedral geometry which allows the soft acid-soft base 
bond formed between Cd+2 and the enzyme to be strengthened 
(due to rr bond formation by donation of the electron pair of 
sulfur to an empty orbital of Cd+2), resulting in enzyme 
inhibition. Thus, of all the metal ions studied, the metal 
ion most likely to function as an in vivo activator of 
normal adult human erythrocytic ALAD and to serve as a 
possible prophylactic and therapeutic agent in the preven-
t . f 1 d . . . z +2 1on or treatment o ea po1son1ng 1s n . 
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If zn+2 is indeed the in vivo activator of ALAD, the 
inhibition of ALAD by Pb+2 may be a result of Pb+2 replacing 
Zn+2 at its binding sites on the enzyme. This, together 
with the fact that ALAD loses most, if not all, of its metal 
ions on purification, would strongly suggest that Zn+2 
activated ALAD is a metal-enzyme complex and not a metallo-
enzyme. In order to confirm whether or not ALAD is a zn+2 
metal-enzyme complex, the stability constant for the binding 
+2 of Zn to the enzyme must be determined~ 
2. A CONSIDERATION OF THE EFFECT OF COPPER ON ALAD 
All of the metal ions in the present study, with the 
exceptions of Cu+2 , have the stable electronic configura-
tions of a noble gas or one in which the subshells are 
either filled or half filled. The usual stable electronic 
f . · of C +2 3d9 · 'b bl h f h con ~gurat~on u , _ , ~s attr~ uta e to t e act t at 
the energies of the 3~ and 4~ orbitals in neutral atoms of 
the first transition series are quite similar but the d 
orbitals become stabilized relative to the s orbitals when 
atoms have an oxidation state of 2 or more. Therefore, 
among the elements of the first transition series, the +1 
oxidation state is rare regardless of its electronic config-
uration. Copper is unusual even in this respect because the 
Cu+ state is important due to its stable, d10 , electronic 
configuration. However, at least in aqueous systems, the 
cu+2 state is the dominant ionic form because of the greater 
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lattice and solvation energies and formation constants for · 
its complexes (Cotton and '.Jilkinson, 1972). 
The borderline Lewis acid Cu+2 has a square planar 
coordination geometry so, as expected on the basis of the 
results obtained for Pb+2 , Sn+2 , Ag+ and Hg+2 , it inhibits 
erythrocytic ALAD at very low concentrations. Having both 
a 3d9 valence electronic configuration with its single un-
paired electron and a characteristic coordination number of 
4, Cu+2 is unable to achieve the electronic configuration of 
a noble gas through cr coordinate bond formation or through 
accepting electrons into empty E. orbitals in the formation 
of a ~ coordinate bond. Cu+2 can, however, donate d orbital 
electrons to the ligand causing inhibition of ALAD that can 
be prevented or reversed by zn+2 . Thus the inhibition of 
ALAD by Cu+2 and its reversal by zn+2 appear to be very 
similar to that of both Pb+2 and Sn+2 . 
Of all the metal ions not investigated in the present 
study, the only other ion that could possibly function as a 
metal ion activator of ALAD on the basis of the observations 
+ of this study is Cu . Cu+ is a soft Lewis base with the 
same d10 valence electronic configuration, characteristic 
coordination number of 4, and tetrahedral coordination 
+2 +2 geometry as Zn and Cd The soft Lewis base nature of 
Cu+ together with its ready oxidation to the powerful ALAD 
inhibitor Cu +2 , however, make this unlikely·. On the other 
hand, cupric copper reacts with mercaptides to give cuprous 
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copper and disulfide in a reversible reaction that proceeds 
to the right if the cuprous ion is stabilized by complexa-
tion with suitable ligands, the strongest of which is RS 
in the absence of air (Kalthoff and Stricks, 1951; Klotz et 
al., 1958; Hemmerich, 1966): 
2Cu +2 + 4RS- ¢ RSSR + CuSR. 
Reduced thiols have been reported to be necessary for the 
maximum activity of erythrocytic ALAD, especially after 
purification of the enzyme, presumably in order to reduce 
oxidized sulfhydryl groups. However, the possibility exists 
that the enzyme loses activity due to air oxidation of the 
essential enzyme activator Cu+ .to the inhibitor Cu+2 during 
the process of purification of ALAD and the in vitro 
analysis of the enzyme activity and reduced thiols are 
necessary for maximum activity because they reduce Cu+2 to 
+ Cu . Reduced glutathione may be necessary for the maintain-
ance of in vivo ALAD activity (Moore et al., 1971) for the 
same reason, maintaining the essential enzyme activator of 
ALAD, copper, in ·its reduced form, Cu+, because the oxidized 
f C +2 · h"b. the L d ld h f orm, u , ~n ~ ~ts enzyme. ea cou , t ere ore, 
inhibit ALAD by reducing GSH concentrations, which it is 
known to do (Shiraishi, 1952; Rubino et al., 1963; Batolska 
and Marinova, 1970), as a result of which Cu+ remains oxi-
dized as cu+2 which inhibits the enzyme. The activity of 
the "lead inhibited" enzyme could then be restored by zn+2 
because it replaces Cu+ with which it is isoelectronic. 
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These suggestions would explain why copper was the only 
metal ion found in stoichiometric amounts in beef liver 
ALAD by Iodice et al. (1958) and why there was a good 
correlation between ALAD activity and the copper content of 
the enzyme from~· sphaerogena (Komai and Neilands, 1968). 
The absolute requirement of ALAD for Cu+2 would be 
very difficult to demonstrate in light of the fact that Cu+ 
+2 immediately disproportionates to Cu and elemental copper 
upon ionization of its soluble salts in water (Cotton and 
Wilkinson, 1972). Cuprous acetonitrile perchlorate, 
Cu(CH3CN) 4clo4 , prepared according to the method of Hemmer-
ich and Sigwert (1963) as modified by Lonti et al. (1965), 
is stable toward hydrolysis in the presence of excess 
acetonitrile (1. 0 H), provided the critical pH of 6 has 
not been exceeded, and could be used in an initial study of 
Cu+ activation of ALAD. Indeed, Cu(CH3CN) 4Cl0 4 has been 
used to reconstitute several Cu+-containing proteins includ-
ing haemocyanin (Lonti et al., 1965) and cytochrome c oxi-
dase (Nair and Hason, 1967). However, its use in studying 
ALAD may present certain difficulties such as the low pH 
and the very high concentrations of the organic solvent 
acetonitrile that must be maintained, especially in light of 
the fact that very much smaller concentrations of another 
organic solvent, ethanol, inhibit ALAD (Moore et al., 1971). 
These difficulties will have to be carefully considered and, 
hopefully, somehow circumvented. 
i 
I, 
I 
I' 
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3. THE IN VIVO INVESTIGATION OF THE EFFICACY OF ZINC AS A 
PROPHYLACTIC OR THERAPEUTIC AGENT IN LEAD POISONING 
In 1972 Willoughby and associates reported the results 
of a study in which groups of young growing horses were fed 
an alfalfa-grass hay mixture plus increasing amounts of a 
basal ration. The basal ration was either a control diet 
(containing 4.0 ppm Pb+2 and 180 ppm zn+2), a diet contain-
ing toxic amounts of Pb+2 only (800 ppm Pb+2 as PbC03 and 
170 ppm zn+2), a diet containing toxic amounts of zn+2 only 
(18 ppm Pb+2 and 5400 ppm zn+2 as ZnO), or a diet containing 
the same toxic amounts of both Pb+2 and zn+2 as the diets 
containing only toxic amounts of Pb+2 or zn+2 over a 23 to 
38 week period. They found that toxic amounts of zn+2 inter-
fere with the uptake of Pb+2 in areas of active bone forma-
tion and result in higher hepatic and renal Pb+2 without 
these high levels being associated w·ith or causing impaired 
neurologic function. Therefore, toxic amounts of zn+2 
appeared to prevent the development of pharyngeal and 
laryngeal paralysis, clinical signs of lead poisoning in the 
young growing horse, but the exact mechanism was unknown. 
In another study Thawley et al. (1977) fed rats lead 
(0.5%), zinc (0.63%), cadmium (90 ppm), and a control diet 
alone and in combination for 42 days with two levels of cal-
cium (0.1 and 0.9%) and three levels of vitamin D (0, 2000. 
and 50,000 IU/kg of feed). They noted a reduction in uri-
nary ALA excretion and lowered blood and tissue lead levels 
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in lead fed rats that were also fed excess zinc. A reduc-
tion in urinary ALA excretion was also observed in lead fed 
rats fed excess cadmium in a low vitamin D diet. These 
authors, however, were unable to determine whether the mech-
anism for the antagonism of the toxic effects of lead by 
zinc was at the level of gastrointestinal absorption or at 
the level of metabolic interference within the hemopoietic 
system. 
Thawley and co-workers (1978) also conducted a study 
in which groups of rats were fed a control diet, a diet con-
taining 0.6% zinc, and a diet containing 0.5% lead and 0.6% 
zinc for six weeks. Two additional groups of rats were used, 
one group receiving the basal diet and intraperitoneal in-
jections of 0.25 ml of a 20% ZnO suspension on the first, 
fourteenth, and twenty-eighth days of the six week experi-
mental period and the others receiving a diet containing 
0.5% lead and the same intraperitoneal injections of a 20% 
ZnO suspension. They found that the oral or intraperitoneal 
administration of zinc resulted in the reduction of urinary 
ALA excretion in lead intoxicated rats to nearly normal 
levels without any significant reduction in blood lead 
levels or any alleviation of the anemia of lead poisoning. 
This led these investigators to conclude that the effect of 
zinc is at a physiologic level beyond gastrointestinal ab-
sorption, presumably reactivating ALAD inhibited by lead or 
preventing inhibition of ALAD by lead. These investigators 
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f d h Pb+2 d . . . d . . f. also oun t at a m1.n1.strat1.on cause a s1.gn1. 1.cant 
decrease in blood zn+2 levels. 
Haeger-Aronsen and associates (1976) recently investi-
gated the effect of lead (as lead acetate), zinc (as zinc 
sulfate), and lead and zinc together in the rabbit when 
injected subcutaneously on the back. One group of animals 
received 63 mg zn+2;kg on day 0 and 200 mg zn+2/kg on day 28; 
another group of rabbits received 18 mg Pb+2/kg on day 0 and 
50 mg zn+2;kg on day 28; a third group of rabbits received 
25 mg Pb+2;kg on day 0 while the fourth group received 25 
mg Pb+2;kg on day 0 and 200 mg zn+2;kg on day 35. They 
found that zinc has a strong activating effect on ALAD in 
vivo, nearly eliminating the inhibitory effect of lead. 
In 1976 Cerklewski and Forbes reported the results of 
an investigation of the influence of dietary zinc on the 
toxicity of dietary lead in the young male rat. Nine groups 
of rats were fed a semipurified diet containing 8, 35, or 
200 ppm zinc (as zinc carbonate) alone or in combination 
with 0, 50, or 200 ppm lead (as lead acetate) over a seven 
week period. They found that as dietary zinc was increased 
the severity of lead toxicity decreased. The evidence for 
this decrease in lead toxicity was: a decreased concentra-
tion of lead in blood, liver, kidneys, and tibias; a de-
creased excretion of urinary ALA; a decreased accumulation 
of FEP; a decreased inhibition of kidney ALAD. In a second 
experiment they investigated the effect of zinc injected 
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intraperitoneally (as zinc sulfate) on the toxicity of 
dietary lead and found it afforded no protection. They 
therefore concluded that the protective effect of zinc 
against lead toxicity is primarily the result of an inhibi-
tion of the intestinal absorption of lead. 
In a similar study Cerklewski and Forbes (1977) 
examined the effect of dietary copper on the toxicity of 
dietary lead in the young male rat. Six groups of rats 
were fed a semipurified diet containing 1, 5, or 20 ppm 
copper (as cupric chloride) alone or in combination with 0 
or 200 ppm lead (as lead acetate) over a four week period. 
They found that as dietary copper increased so did the 
severity of the lead toxicity. The evidence for the in-
creased lead toxicity was an increased lead concentration in 
the kidney and a two- to threefold increase in the excretion 
of urinary ALA. These investigators hypothesize that the 
increasing dietary copper concentration may have a modifying 
effect on other trace elements (such as zinc), producing 
more favorable conditions for the development of lead 
toxicity. 
A recent article (Thomasina et al., 1977) reports the 
interesting case of a lead intoxicated 37 year old male with 
an extremely high blood lead level (260 ~g/100 ml of whole 
blood) studied before and after treatment with Na2 (Ca-EDTA) 
and then before and after oral administration of zinc sul-
fate. Immediately after 5 days of daily parenteral doses 
of 500 mg Na2 (ca-EDTA) the blood lead level was 100 ~g/ 
100 ml of whole blood and continued to fall until, at 49 
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days after the onset of chelation therapy, it was 55 ~g/ 
100 ml of whole blood. Serum zinc concentrations fell from 
146 to 68 ~g/100 ml during chelation therapy while 24 hour 
urinary zinc excretion rose dramatically, reaching a peak 
of nearly 7000 ~g/24 hours during the last day of therapy 
which was nearly five times higher than the highest preche-
lation value. During chelation therapy more than 27,281 ~g 
of zn+2 was excreted which was nearly four times more than 
the 7700 ~g of Pb+2 excreted. Erythrocytic ALAD activity 
was 20% of the control value prior to chelation therapy, 
declined to 12.2% of control during chelation, and rose to 
25.5% of control on the day after chelation was discontinued. 
Thirty-six days after chelation therapy ended 100 ~g of zinc 
sulfate was administered orally to the patient three times a 
day for five days. The zinc sulfate therapy had little 
~ ~ . ~ effect on the serum Zn , blood Pb , ur~nary Zn , or 
. Pb+2 . ur~nary concentrat~ons. There was, however, a signifi-
cant increase in erythrocytic ALAD activity to 35% of the 
+2 control value as a result of the Zn therapy. On the basis 
+2 of these results the authors concluded that Zn may play a 
. 1 . 1 d . . d z +2 1 . protect~ve ro e ~n ea tox~c~ty an n supp ementat~on 
may be a useful adjunct to chelation therapy for lead 
toxicity. Unfortunately these results are not as clear 
cut as they might have been since the biggest decrease (50%) 
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in both blood lead and serum zinc were observed as a result 
of eight days of hospitalization prior to the onset of che-
lation therapy. The decreased blood lead is most likely due 
to a discontinuation of exposure to the environment of the 
lead battery factory where the subject was employed while 
the decreased serum zinc may be due to a discontinuation 
of exposure to the several pints of whiskey he consumed 
daily for several years. 
N h 1 h . h z +2 1 . onet e ess, t e suggest~on t at Jn supp ementat~on 
may be useful adjunct to chelation therapy for lead 
toxicity or a useful prophylactic agent for preventing lead 
toxicity seems reasonable. The reasons for this bear 
reviewing: 
a. Pb+2 inhibits erythrocytic ALAD 
b. Pb+2 causes a significant decrease in the serum 
zn+2 concentration 
c. Na2 (Ca-EDTA) therapy results in a marked increase 
. h . . f z +2 d d ~n t e ur~nary excret~on o n an a correspon -
ing fall in serum zn+2 levels 
d Z +2 d f. . 1 . k d d . . n e ~c~ency resu ts ~n a mar e ecrease ~n 
erythrocytic ALAD activity 
e. inhibition of ALAD contributes significantly to 
the anemia of lead poisoning 
f. inhibition of ALAD results in a dramatic accumula-
tion of the substrate ALA in the serum and various 
organs 
g. the increased levels of ALA may be responsible 
for some of the neurologic, gastrointestinal, and 
cardiovascular symptoms of lead poisoning 
h. zn+Z activates and prevents or reverses Pb+Z_ 
induced inhibition of erythrocytic ALAD in vitro 
i. toxic levels of zn+Z prevent or reverse the toxic 
effects of Pb+Z in vivo at the level of gastroin-
testinal absorption, at the level of interference 
with the hemopoietic system, or at both levels 
j. zn+Z can be administered in very large doses with-
out toxic effects (National Research Council Sub-
cormnittee on Zinc, 1979). 
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Before zn+Z supplementation is used as a prophylactic agent 
or therapeutic adjunct in the prevention or treatment of 
lead poisoning it is desirable to understand whether zn+2 
primarily prevents the gastrointestinal absorption of Pb+Z 
or prevents or reverses the Pb+2-induced inhibition of ALAD 
so a protocol for zn+Z supplementation can be established 
for each use. 
In determining the site of zn+Z interference with lead 
toxicity a most important consideration is the choice of an 
animal model. While no single species is an exact model for 
the effect of lead in man, the rabbit is among the few ani-
mals in which lead poisoning interferes with porphyrin metab-
olism as it does in man (Hass et al., 1964; Scharding and 
Oehme, 1973) and the location and sequence of the development 
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of renal pathology resemble those of man (Hass et al., 1964; 
Macadam, 1969; Scharding and Oehme, 1973). In addition, 
the activity of rabbit erythrocytic ALAD is one of the few 
erythrocytic ALAD activities that is at least as high as 
that of man (Abdulla et al., 1978a). The rabbit, therefore, 
seems to be a logical choice as an animal model for this 
study. 
+2 In order to evaluate the efficacy of Zn as a pro-
phylactic agent for the prevention of lead poisoning or as 
a therapeutic agent for the treatment of lead poisoning the 
following protocol is proposed and could be modified as the 
need arose. Fifty-six young adult male New Zealand white 
rabbits should be divided into seven groups of eight and 
fed a control diet, a control diet supplemented with zinc 
acetate, a control diet supplemented with lead acetate, or 
a control diet supplemented with both Pb+2 and zn+2 . The 
daily lead dose should be chosen because it is sublethal 
and the zn+2 dose should be chosen so as to provide a molar 
concentration of zn+2 that is equal to or twice the molar 
concentration of the sublethal dose of lead but is itself 
subtoxic. The seven groups could be: 
a. animals fed a control diet 
b. animals fed 20 +2 mg Pb /kg/day in a control diet 
for 24 weeks 
animals fed 6.3 +2 in a control diet c. mg Zn /kg/day 
for 24 weeks 
. +2 +2 d. an~mals fed 20 mg Pb /kg/day and 6.3 mg Zn I 
kg/day in a control diet for 24 weeks 
e. animals fed 20 mg Pb+2/kg/day in a control diet 
for the first 12 weeks and a control diet for 
the last 12 weeks 
f. animals fed a control diet for the first 12 weeks 
and 6.3 mg zn+2/kg/day in a control diet for the 
last 12 weeks 
g. animals fed 20 mg Pb+2/kg/day in a control diet 
for the first 12 weeks and 6.3 mg Zn+2;kg/day in 
a control diet for the last 12 weeks 
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At the end of the experimental period the animals 
should be weighed and 24 hour urines collected. The animals 
can then be sacrificed, blood collected in the appropriate 
Vacutainer tubes, and the following determined on the blood 
and urine: 
a. 24 hour urinary output 
b. serum and urinary creatinine 
c. complete blood count 
d. reticulocyte percent 
e. erythrocytic ALAD activity, unactivated by zn+2 
and activated by zn+2 so the ratio can be 
determined 
f. serum and urinary ALA 
g. whole blood and urinary lead 
h. serum and urinary zinc 
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i. serum copper 
j. serum iron 
(It is necessary to determine serum copper because zinc is 
reported to act as a copper antagonist (Hill, 1976) and 
serum iron in order to rule out iron deficiency anemia.) 
Upon analyzing these results using an analysis of variance 
one should be able to determine at which site zn+2 antago-
nizes the toxic effects of Pb+2 . 
In addition to the above measurements at the end of 
the above experiment it might be interesting to do some 
histology on at least the kidney and perhaps also the liver 
and bone marrow in order to determine whether or not zn+2 
prevented any lead-induced change in their histology. 
Once it has been determined at which site or sites 
zn+2 is acting, its efficacy as a prophylactic agent or 
therapeutic adjunct should be apparent. If zn+2 is indeed 
potentially valuable as a therapeutic adjunct, further 
studies can be conducted in order to determine the proper 
doses of zn+2 to be used in conjunction with Na2 (ca-EDTA) 
and the times at which the doses should be administered with 
respect to the times of administration of the chelating 
agent. If zn+2 is indeed potentially valuable as a pro-
phylactic agent, further studies can be conducted in order 
to determine the proper doses of zn+2 to be used for the 
various routes and levels of lead exposure. 
CHAPTER VI 
Sill1MARY 
CHAPTER VI 
SUMMARY 
A correlation between blood reticulocyte percent and 
the activity of erythrocytic ALAD in the developing rat has 
been established during the progression from a state of 
macrocytic hypochromic anemia at birth to a normocytic 
normochromic state at puberty and, finally, to a state just 
prior to adulthood at which the reticulocyte percent had 
stabilized. Both reticulocyte percent and erythrocytic 
ALAD activity were found to decrease with age, rapidly at 
first until a normocytic normochromic state was reached at 
puberty and then more slowly until just before adulthood 
when both plateaued. A direct, linear correlation between 
erythrocytic ALAD activity and blood reticulocyte percent 
was found with a P value of less than 0.001. These findings 
should be carefully considered when using the rat as a model 
for lead poisoning and, possibly, for other disorders of 
heme synthesis. 
When establishing reference values for the ALAD activi-
ty of normal, healthy, nonmedicated adult male and female 
volunteers a highly significant difference was found between 
the mean male ALAD activity of 44.2 mU/ml RBC and the mean 
female ALAD activity of 48.2 mU/ml P~C, with a P value of 
less than 0.01. While the biological significance of this 
148 
149 
difference is uncertain at the present time since it has 
been suggested that there is excess enzyme present in the 
body, it should, nonetheless, be considered when establish-
ing reference values for the erythrocytic ALAD assay. 
It was the major objective of this work to determine, 
+ in a dose-response fashion, the in vitro effects of Na , 
M +2 Al+3 Mn+2 C +2 A + Z +2 Cd+2 H +2 G +3 I +3 g , , , u , g , n , , g , a , n , 
S +2 and Sn+4 on 1 h · ALAD d n , norma eryt rocytLc an on an 
enzyme 50% inhibited by Pb+2 while at the same time examin-
ing the ability of a maximally stimulatory concentration of 
. 1 . d' d . z +2 an actLvator meta Lon Lscovere on screenLng, n , to 
prevent or reverse the effects of these metal ions. As a 
result of this work several important conclusions were 
reached concerning the physical and chemical properties 
associated with the ability of a metal ion to activate or 
inhibit human erythrocytic ALAD. All hard Lewis acids, 
regardless of valence electronic configuration or oxidation 
state, were found to have no significant effect on ALAD 
activity except at very high concentrations. Divalent zinc 
and cadmium, borderline or soft Lewis acids having character-
istic coordination numbers that give them the electronic 
configuration of noble gases, were the only ions found to 
activate erythrocytic ALAD and to prevent or reverse the 
Pb+2 . d d . h'b' . f th z +2 ld -Ln uce Ln L LtLon o e enzyme. n cou prevent 
or reverse the in vitro inhibition of ALAD by low concen-
trations of borderline Lewis acids having characteristic 
150 
coordination numbers that give them the electronic config-
uration of noble gases and a planar coordination geometry 
that allow rr bonding through donating electrons into an 
empty d orbital of a ligand. +2 Zn could not, however, pre-
vent or reverse the inhibition of ALAD induced by low con-
centrations of soft Lewis acids having characteristic coor-
dination numbers that do not give them the electronic config-
uration of noble gases and a planar coordination geometry 
that allows rr bonding through accepting electrons from a 
ligand into an empty £ orbital. On preincubation with the 
enzyme for as little as one-half hour the soft Lewis acid 
Cd+2 only inhibited ALAD but the borderline Lewis acid zn+2 
could still activate ALAD after preincubation with the 
enzyme for as long as four hours. These results suggest 
that the metal ions are affecting the activity of ALAD by an 
interaction with the sulfhydryl groups of enzyme. These 
results also suggest that zn+2 is possibly the in vivo metal 
ion activator of the metal-enzyme complex ALAD but do not 
l.•t l.·s cu+ and not zn+2 that rule out the possibil:ity that is 
the activator of ALAD. +2 It is proposed that Zn be used as 
a prophylactic agent or therapeutic adjunct to prevent or 
reverse the Pb+2-induced inhibition of ALAD and the result-
ing anemia and possibly toxic accumlation of the substrate 
ALA. 
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FIGURE 5. 
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.. 
The variation of various hematologic indices, 
including hemoglobin, hematocrit, mean corpuscular volume 
(MCV), and mean corpuscular hemoglobin (MCH), with the age 
of the male albino rat. Each point represents the average 
of results obtained from three animals. (J') 
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FIGURE 6. The variation of blood reticulocyte percent with 
the age of the male albino rat. Each point represents the 
average reticulocyte percent per 1000 erythrocytes counted 
for each of three animals. 
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FIGURE 7. The variation of erythrocytic ALAD activity with 
the age of the male albino rat. Each point represents the 
average of results obtained from three animals. (J) 
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FIGURE 8. The relationship between erythrocytic ALAD 
activity and blood reticulocyte percent. Each point repre-
sents the determination of ALAD activity and reticulocyte 
percent in each of 27 individual male albino rats studied. 
The correlation coefficient (r) was determined to be 0.967 
with a P value of less than 0.001. 
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FIGURE 9. The concentration curve for the effect of Cu+2 
on normal adult human erythrocytic ALAD activity in vitro. 
Each point represents the mean ± S.E.M. of results obtained 
for 4 individuals. 
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FIGURE 10. The effect of various concentrations of Pb+2 , 
zn+2, Cd+2 , and Hg+Z on normal adult human erythrocytic ALAD 
activity in vitro. Each point represents the mean ± S.E.M. 
of results obtained for 4 individuals. 
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FIGURE 11. The effect of zinc acetate on lead acetate-
induced inhibition of normal adult human erythrocytic ALAD 
in vitro. Lead and zinc were added to the hemolysates 
immediately prior to the 1.0 hour incubation with ALA at 
37°C. Each point represents the mean ± S.E.M. of results 
obtained for 11 individuals. 
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FIGURE 12. The effect of zinc acetate on copper acetate-
induced inhibition of normal adult human erythrocytic ALAD 
in vitro. Copper and zinc were added to the hemolysates 
immediately prior to the 1.0 hour incubation with ALA at 
37°C. Each point represents the mean ± S.E.M. of results 
obtained for 6 individuals. 
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FIGURE 13. The concentration curves for the effect of zn+Z 
of rn50 Pb+Z_ and on rn50 Cu+
2
-induced inhibition of 
normal adult human erythrocytic ALAD activity in vitro. 
Each point represents the mean ± S.E.M. of results obtained 
for 11 or 6 individuals, as indicated on 'the graph. 
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FIGURE 14. The concentration curves for the effect of zn+2 
on rn90 Pb+Z_ and on rn90 Cu+
2
-induced inhibition of normal 
adult human erythrocytic ALAD activity in vitro. Each 
point represents the mean ± S.E.M. of results obtained for 
11 or 6 individuals, as indicated on the graph. 
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FIGURE 15. The effect of various concentrations of Pb+2 , 
Z +2 n , Cd+2 , and Hg+2 on normal, rn50 Pb+
2 inhibited, 
zn+
2 
stimulated adult human erythrocytic ALAD 
and 
activity in vitro. Each point represents the mean ± S.E.M. 
of results obtained for 4 individuals. 
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FIGURE 16. The concentration curves + for the effect of Na , 
Pb+2 inhibited, and 
sn100 Zn+
2 
stimulated adult human erythrocytic ALAD activity 
in vitro. Each point represents the mean ± S.E.M. of 
results obtained for 4 individuals. 
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FIGURE 17. The effect of various concentrations of Ag+ on 
normal, rn50 Pb+Z inhibited, and sn100 Zn+Z stimulated 
adult human erythrocytic ALAD activity in vitro. Each point 
represents the mean ± S.E.M. of results obtained for 4 
individuals. 
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FIGURE 18. The concentration curves for the effect of Ga+3 
+3 +2 +2 and In on normal, In50 Pb inhibited, and sn100 Zn 
stimulated adult human erythrocytic ALAD activity in vitro. 
Each point represents the mean ± S.E.M. of results obtained 
for 4 individuals. 
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FIGURE 19. The concentration curves for the effect of Sn+2 
+4 +2 +2 
and Sn on normal, rn50 Pb inhibited, and sn100 Zn 
act.ivated adult human erythrocytic ALAD activity in vitro. 
Each point represents the mean ± S.E.M. of results obtained 
for 4 individuals. 
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FIGURE 20. The effect of 1.0 hour preincubation with Pb+2 
+2 +2 +2 . 
and Hg on Pb - and Hg -~nduced inhibition of normal 
adult human erythrocytic ALAD activity in vitro. Each 
point represents the mean ± S.E.M. of results obtained for 
4 individuals. 
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FIGURE 21. The effect of 1.0 hour preincubation with Zn+2 
and Cd+2 on Zn+2 and Cd+2 activation and Cd+2-induced inhi-
bition of normal adult human erythrocytic ALAD activity in 
vitro. Each point represents the mean ± S.E.M. of results 
obtained for 4 individuals. 
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FIGURE 22. The effect of 0.5, 1.0, 2.0, and 4.0 hour pre-
incubation with Pb+2 on Pb+2-induced inhibition of normal 
adult human erythrocytic ALAD activity in vitro. Each 
point represents the mean ± S.E.M. of results obtained for 
4 individuals. 
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FIGURE 23. The effect of 0.5, 1.0, 2.0, and 4.0 hour pre-
incubation with Pb+2 on the inhibition of normal adult 
human erythrocytic ALAD induced by various concentrations 
of Pb+2 in vitro. Each point represents the mean ± S.E.M. 
of results obtained for 4 individuals. 
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FIGURE 24. The effect of 0.5, 1.0, 2.0, and 4.0 hour pre-
incubation with Cd+2 on Cd+2-induced stimulation and Cd+2-
induced inhibition of normal adult human erythrocytic ALAD 
activity in vitro. Each point represents the mean ± S.E.M. 
of results obtained for 4 individuals. 
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FIGURE 25. The effect of 0.5, 1.0, 2.0, and 4.0 hour pre-
incubation with Cd+2 on the stimulation and inhibition of 
normal adult human erythrocytic ALAD induced by various 
. f Cd+2 . . concentrat~ons o ~n v~tro. Each point represents the 
mean ± S.E.M. of results obtained for 4 individuals. 
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FIGURE 26. The effect of 0.5, 1.0, 2.0, and 4.0 hour pre-
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adult human erythrocytic ALAD activity in vitro. Each 
point represents the mean ± S.E.M. of results obtained for 4 
individuals. 
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FIGURE 27. The effect of 0.5, 1.0, 2.0, and 4.0 hour pre-
incubation with zn+2 on the stimulation of normal adult 
human erythrocytic ALAD induced by various concentrations 
f Z +2 . . o n ln Vltro. Each point represents the mean ± S.E.M. 
of results obtained for 4 individuals. 
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FIGURE 28. 
.. 
normal adult human erythrocytic ALAD activity when added 
in vitro without, before, and afte~ a 1.0 hour preincuba-
tion of the hemolysate. Each point represents the mean ± 
S.E.M. of results obtained for 4 individuals. 
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added before and after preincubation on preincubation 
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2
-induced inhibition of normal adult human erythro-
cytic ALAD activity in vitro. Each point represents the 
mean ± S.E.M. of results obtained for 4 individuals. 
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FIGURE 30. The effect of preincubation with various con-
centrations of zn+2 on preincubation and nonpreincubation 
rn50 Pb+
2
-induced inhibition of normal adult human erythro-
cytic ALAD activity in vitro. Each point represents the 
mean ± S.E.M. of results obtained for 4 individuals. 
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